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SUMMARY
The objective of this thesis is to question the 
relationship between diet and sleep in Man, by means of a 
model relating carbohydrate intake, plasma amino acids, and . 
sleep patterns.
Experimental findings suggest that hunger, starvation 
and weight loss are associated with various measures of 
increased arousal, while satiety, food intake and weight 
gain correlate with decreased arousal. The relationship 
can be observed biochemically, physiologically, behaviorally 
and psychologically.
Lowered arousal after eating in turn correlates with 
a variety of factors ranging from the age, sex and habits 
of the individual to the temperature, quantity and nature 
of the food eaten. The relationship has been consistently 
reported with carbohydrate.
Carbohydrate may function to lower arousal via the 
pathway to brain serotonin, a neurotransmitter thought to 
mediate sleep. Evidence suggests that the insulin response 
to ingested carbohydrate results in an advantage for 
L-tryptophan in competition with other neutral amino acids 
for blood/brain transfer. Brain tryptophan concentration 
is the rate-limiting factor in serotonin synthesis.
To test this model, twelve young men were given either 
fat, carbohydrate, protein or no supplement, in the form 
of a drink with the evening meal, in balanced order.
Plasma was sampled hourly throughout the night and analysed 
for tryptophan, tyrosine and phenylalanine. The Subject's 
sleep was recorded electrophysiologically.
The results showed the carbohydrate supplement to be 
associated with an increased ratio of tryptophan to tyrosine, 
compared with the other diets. The ratio of tryptophan to 
tyrosine plus phenylalanine was greatest with protein.
E.E.G. sleep did not vary with the amino acid ratios, 
however subjects chose to go to bed earlier after carbo­
hydrate supplement.
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TST total sleep time
TRT total recorded time
TDT total defined time
REM rapid eye movement sleep, also known as
PS paradoxical sleep .
NREM non-rapid eye movement sleep
SWS slow wave sleep
MT movement time
EEG electroencephalogram
ECOG electro-corticogram
EOG electro-oculogram
EMG electro-myogram
PRS post reinforcement synchronization
tryp* tryptophan, tryptophane
tyr tyrosine
phe phenylalanine
leu leucine
isol isolencine
val valine
5-HTP 5-hydroxytryptophan
5-HT 5-hydroxytryptamine, serotonin
5-HIAA 5-hydroxyindoleacetic acid
PCPA para-chlorophenylalanine
hGH human growth hormone
CCK cholecystokinin
PK pancreozymin
CHO carbohydrate
FFA free fatty acids
Km Michaelis constant
RAS Reticular Activating System
*Note: Amino acids appearing in the text refer to the
laevo-rotatory form unless otherwise specified.
PREFACE
The work reported in this thesis is an attempt to throw 
more light on relationships between nutrition and sleep.
An experiment is presented which set out to test the hypo­
thesis that varying, relative amounts of carbohydrate, fat 
and protein in the diet would affect human sleep in predictable 
ways, via a specific model of neutral amino acid metabolism, 
in the pathway to neuronal serotonin. As such, the study 
undertaken is one approach to unravelling the mechanisms of 
sleep: and, ultimately, the question of why we sleep.
Such an approach is, by design, multidisciplinary: 
an attempt to reveal correlations between phenomena at 
several levels of biological organisation. Specifically, 
the objective has been to correlate the observed impact of 
an experimental variable at the biochemical level, with 
recorded physiological activity, and reported psychological 
experience. This design reflects three implicit methodo­
logical positions:
1) Because sleep can be understood on many levels, 
and because the different levels of explanation are 
valid concurrently, enquiry into the nature of sleep 
is, by definition, multidisciplinary.
2) Adequate investigation into sleep must, therefore, 
take the special logical constraints of multidisciplinary 
enquiry into account in addition to the technique, 
terminology and concepts which are the province of
each individual discipline.
3) Research into sleep in Man (if not elsewhere in 
the sleeping world) invites the researcher to consider 
and include in his treatment, the existence of mind:
and the relationship of mind to brain. This is an 
issue common to the field of neurobiology in general, 
but perhaps nowhere more accessible to examination 
than in its sub-section, sleep research.
To take each point, briefly, in turn:
It is striking that after more than thirty years of 
increasingly intensive research into sleep a satisfactory 
definition of its function, with heuristic value for why 
it should be an all but universal fact of mammalian and 
avian existence, remains elusive. This is not true of 
other similarly innate biological needs. After all, we 
know why we have sex, for example, and indeed why we need 
to eat. We can see a relationship in these two behaviours 
between the respective appetite in an individual and function 
for the species. The biological significance of tiredness 
and sleep is less clear, however, despite the obvious 
deduction that, as with sexuality and hunger, the periodic 
drive to sleep has in some way afforded survival value in 
evolution. This is the case, in my view, for two reasons:
1) As one component of an evolved form of rest/ 
activity cycle, sleep - like feeding and reproduction - 
is so fundamental a property of living systems that it 
is difficult to tease out its function at a complex 
level of biological organisation from this elemental 
fact of its nature.
2) Unique among such fundamental properties of life 
- and therefore unlike feeding and reproduction - 
sleep cannot be defined separate from wakefulness: 
they are manifestationsof the same cycle: mirror 
images of one and the same phenomenon. This embroils
the sleep researcher in definitions of mind and con­
sciousness, and in the question of their possible 
evolution.
At the same time there exists a tantalising wealth of 
descriptive - one might say circumstantial - evidence about 
sleep, from various scientific disciplines. A schema for 
visualising the relationships between the disciplines has 
been proposed by Steven Rose (fig 1). I have found it 
useful to order my knowledge of and thoughts about sleep 
according to this schema. It occurred to me in the course 
of this exercise that the phenomenon of sleep can be equally 
well understood at every level of biological explanation; 
that the 'how* of its function and the 'why® of its function 
are two logically distinct issues which do not necessarily 
go hand in hand; and that it may be simplistic and mis­
leading to look to any one level - eg neuro-biochemical - 
for an ultimate definition of sleep function.
At the level of physics, for example, sleep might be 
understood simply as one peak in an oscillating system, 
the other peak, being wakefulness. The question then 
becomes 'why an oscillating system'? Oscillating systems 
combine the properties of stability (like steady-state 
systems) and change (unlike steady-state systems); they 
are said to be'metastable'. In evolutionary terms, such 
a system might well have survival value because of its 
potential for adaptation within limits.
As with most explanations at the lower hierarchical 
levels, the above example is characteristically simple, 
fundamental and generalizable. On the other hand it lacks 
the detail appropriate to its corollaries at other levels 
of explanation. Equally, one can think in terms of the
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(Reprinted with permission from Rose,- 1976)
xi
biochemistry of sleep; the physiology, psychology, socio­
logy of sleep. Each hierarchical level can be seen as 
describing its own terms of reference, within which all 
are equally valid, have equal explanatory power. In 
defining a phenomenon such as sleep, the clarity and 
simplicity appropriate to one level of understanding may 
complement the detail and applicability appropriate to another, 
and vice versa. This is not to suggest that all levels 
(disciplines), will be equally useful at any given time, 
however. Which explanations are useful is dependent on 
the intended objective, or what question is being posed; 
e.g. is the metabolism of foodstuffs related to the bio­
chemistry of sleep?
Methodologically and conceptually confusion may arise 
because the different levels of explanation are valid 
concurrently. 'Points on each line (of the pyramid) 
correspond to points on all lines below and above ....
(and) therefore represent equivalent statements in different 
universes of discourse (Rose, 1976)'. As a result, a 
series of logical constraints become obligatory in multi­
disciplinary research:
.... it must be emphasized that in establishing
this hierarchy we are not suggesting that the 
boundaries between levels are necessarily 
absolute .... We may regard the hierarchy 
boundaries as defined operationally, in terms 
of how we handle questions and problems at any 
level, and why we are asking of our subject 
matter the particular questions which interest 
us ....
In the same way, one may view the various scientific 
disciplines as open ended, inter-relating, and 'operationally' 
defined. Moreover,
.... confusion may arise of one regards these
hierarchical levels as rigid - made by nature 
rather than man - or if attempts are made to 
cross the levels of the hierarchies of explan­
ation. If, for instance, one says ’(being 
asleep)' is caused by changes such and such 
in molecular structure in the brain, one is 
attributing a causal relationship between the 
point set on one level and that on another, 
where it is not always legitimate to attribute 
more that a correlative relationship ....
Such causal statements imply both a temporal 
sequence - one event always precedes the other - 
and a non-reversibility: Either A causes B
or B causes A . A correlative relationship, 
on the other hand, does not imply that one 
event is the result of another, merely that 
when one event occurs, the second also invariably 
takes place: when the state '(being asleep)1
occurs, then such and such changes in molecular 
structure also always occur (Rose, 1976).
In addition to the research model discussed above, 
however, there remain the mind/brain implications of
sleep which, unless explicitly confronted, in my view 
obscure and confuse efforts to define its fundamental 
nature. What is mind? Can it, theoretically, be 
understood in terms of brain function? Can it be said 
to have evolved? How does it relate to consciousness? 
That this relationship is not more often explicitly dealt 
with by sleep researchers - despite its patent relevance 
to sleep is understandable ... so much so that its 
absence is rarely questioned. The nature of conscious­
ness, mind and thought have traditionally been defined 
within the province of philosophy or religion, as issues 
which require ideological positions not appropriate to 
scientific method. The deceptively simple question 
'what is sleep?' challenges this tradition.
With the isolation of so-called sleep and wakefulness 
'centers' to the brainstem nucleii (French, I960; Jouvet, 
1967; Morgane & Stern, 1975), and the finding of strong 
correlations between specific EEG patterns and different 
states of consciousness, the relevance of brain activity 
for mind became an inescapable issue for sleep research. 
However one chooses to define 'mind' and 'consciousness', 
whether one posits their rational or irrational derivation, 
both can be said to find correlates in brain function.
The brain is, in some sense as yet largely undefined, 
common to both mind and body. As the brain normally 
sleeps and wakes, so do the body and the mind, within 
their appropriate terms of reference.
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The importance of sleep for both body and mind has 
been described and theorized. Hartmann, designating 
'Two Kinds of Tiredness' postulates that 'physical 
tiredness' represents a need for slow wave sleep, while 
'mental tiredness' a need for D-State or REM sleep 
(Hartmann, 1973). These categories are consistent 
with the widely held theory of sleep function, first 
published by Oswald in 1970, that slow wave sleep 'serves 
a function for the growth and renewal of general bodily 
tissues', while REM sleep promotes those synthetic 
processes which restore 'our brains or our hurt minds' 
(Oswald, 1970).
Sleep, as a phenomenon of both body and mind, has 
been seen as affording unique opportunities to test 
psychobiological hypotheses: there is the large literature
on REM sleep and memory for example; on sleep deprivation 
and mental acuity; on intelligence, total sleep time and 
%REM; on cognitive biases and dream recall. The influence 
of drugs on both mental state and sleep physiology is 
widely investigated. -Various clinical conditions, con­
sidered as psychosomatic, have been studied in relation 
to sleep: migraine, enuresis, excema, anorexia nervosa.
In all of the above descriptions, theories, hypotheses 
some concept of mind has been incorporated. Rarely is the 
term, or the sense in which it is used, defined. I sug­
gest that implicit assumptions about the nature of 
mind operate with particular significance in sleep 
research, and that it is difficult adequately either
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to conduct or to criticise work in which the experimenter's 
notion of mind is left undefined.
It is not my purpose here to argue for any one explan­
ation of the existence of mind. The sense in which the 
term is used in this study is set out below. The point, 
in my view, is that because sleep is an event of the mind 
as well as the body, an expressed working definition of 
mind is necessary to its adequate investigation.
The definition of mind I am adopting is a particular 
interpretation of what is known as the 'identity hypothesis' 
(Place, 1956). For the purposes of this study mind is 
defined as equivalent to 'the sum total of brain activity' 
within the hierarchy of biological explanation situated 
between those of physiological systems, and social psychology. 
Consciousness is defined as the 'continuously developing 
activity of minds/brains in interaction with their environ­
ment, modified, either temporarily or permanently by 
changing circumstances' (Rose, 1976). Sleep and wakefulness 
are then seen as examples of temporary modifications of 
consciousness in minds/brains, brought about by changes 
in circumstances not fully understood, with correlates at 
all levels of biological explanation.
In Chapter 1, I propose to examine the case for certain 
of these correlates.
1CHAPTER ONE 
LITERATURE SURVEY
2A. Work correlating food intake with relative arousal levels.
1. Introduction
At relatively simple stages in biological evolution, 
activity and rest appear to cycle around ingestion of nutrients. 
"Even among the lowest types of unicellular animals and plants, 
that possess no nervous system, hunger manifests itself 
strongly enough to cause visibly increased motility and cell 
excitability (Wada, 1922)". With structural elaboration in 
the course of evolution, both phylogenetic and ontogenetic, 
each of these behaviors may achieve new forms.
With the reptilian, sub-cortical level of development, 
for example, it becomes possible to discern a primitive 
wakeful form of activity and a sleep-like form of rest; to 
think in terms of instincts with a quality of drive, repres­
enting an advance over reflex; and to speak more appropriately, 
perhaps, of hunger' and * satiation*.
With the emergence of the first true mammals, and neo- 
cortical elaboration of limbic structures, metabolism capable 
of maintaining constant body temperature has evolved; wake­
fulness has assumed appetitive, emotional and purposive forms 
of activity; sleep further differentiates into slow wave, then 
REM, forms. At this stage it becomes possible to think in 
terms of a psychological aspect, with abstraction and object 
differentiation, perception and action.
At the human, asymmetric neocortical level, activity, 
rest and ingestion of nutrients have achieved vastly elaborated 
forms as ontogeny recapitulates phylogeny, consciousness 
develops by means of language, and volition becomes possible.
3At this stage, an individual can - to some, ill-defined 
extent - choose when to rest, when to be active, and when 
to eat, from a wide vocabulary of behavioral forms. The 
range of choice available has limits, the extremes of which 
may be considered pathological. Within them, however, the 
human animal may bring his own psycho-logic* to an environ­
ment once governed by reflex, instinct, drive.
The recently-defined field of chronobiology can be 
understood as an attempt to define the nature of such 
phylogenetically ancient rhythms as rest/hunger/activity, 
and the extent to which they may prescribe human behavior.
For instance: Kleitman*s work to isolate the operation of
a"basic rest/activity cycle", correlated with oral behavior, 
as observed in various species-specific behavior patterns 
(Kleitman, 1963). Jason Brown (Brown, 1977) presents the 
case for a "hunger-sleep complex" suggested to define (with 
sexual drive) behavior at the subcortical level. Brown 
theorizes that emotional, cerebral and symbolic forms of 
consciousness can be understood as derivations of these prim­
itive drive forms, appropriate to subsequent stages in 
mammalian evolution, viz:
"(At the limbic level) Anger represents 
the action-related, fear the perception- 
related, manifestation of what, at the 
preceeding stage, constituted the hunger^ 
sleep complex . . .  The prominence of 
either action or perception tends to 
inactivate the other component. Sleep 
requires a suspension of motility.
Hunger begins as an activity . . . This 
relationship between the drives can be 
seen in human infants, where the global 
drive state of hunger leads, in feeding,
4to rhythmic action, such as in sucking 
and associated body movements. This
coincides with an attenuation of the
drive and finally gives way to the 
opposite drive state, sleep, or satia­
tion. These manifestations of instinct­
ual hunger and sleep reappear later on 
in adult sexuality."
We speak of being hungry or tired in a metaphorical
sense: "Hungry" for knowledge, power, money: "tired" of this
or that activity, meaning - not necessarily sleepy - but not
actively interested . . . not "hungry", perhaps. G Stanley
Hall in his book Adolescence suggests, "the true beginning
of a psychology essentially genetic is hunger, the first
sentient expression of the will to live (in Wada, 1922)."
The work cited below purports to relate various patterns
of food intake to relative arousal, both physiological and
psychological. I have used the term ‘arousal* here in order 
to avoid the potentially confusing concept of gross body 
movement associated with the term 'activity* , which may or 
may not accompany arousal.
2.a) Hunger versus Satiety : Arousal
In a series of small studies in 1922, Wada observed:
(1) that subjective reports of hunger coincided 
in time with periodic stomach contractions, 
as measured by a swallowed balloon connected 
to an air pressure recorder. No sensation 
of hunger was signalled during stomach 
quiescence;
5(2) that body movements , recorded by means 
of a bedspring motility apparatus, 
occurred simultaneously with maximal 
stomach contractions in both sleep and 
resting wakefulness;
(3) and that both motor aptitude (hand 
dynamometer test) and mental efficiency 
(Thorndike Intelligence Tests) were 
increased during stomach contractions 
versus quiescence. She also noted an 
increase in the "frequency and vigor" 
of periodic body movements during 
infant sleep prior to regular feeds 
(Wada, 1922).
Wada*s investigations, while well controlled and 
documented, included only one or two individuals per 
study, without statistical validation of her apparently 
significant correlations. Her observations in infants 
were confirmed, however, in a later study by Irwin (Irwin, 
1932) of motility distribution in 73 full-term newborns 
between nursing periods. Using a stabilimeter-polygraph 
technique Irwin found, despite individual variation, an 
increase in the mean motility of the infants from 17.0 
oscillations/minute in the first 15 minute period after 
nursing to 45 oscillations/minute during the last 15 minute 
experimental period prior to nursing. A correlation 
coefficient of .97 - .04 was obtained between mean 
motility and lapse of time over the group. Observed
6wakefulness was found not to influence the motility scores. 
Citing earlier evidence (Carlson, 1918) of, in general, 
increased "hunger contractions" with time elapsed since 
eating, and augmented central nervous system activity 
during such contractions (as measured by knee-jerk, 
salivation and heart-action vasomotor changes), Irwin 
concluded, "the hypothesis that the motility in most of 
these infants is correlated with hunger contractions of 
the stomach seems reasonable".
That motor activity may increase as a function of 
hours food deprivation was further demonstrated in two 
investigations in the rat. Studying four animals in 
tambour-supported cages, Richter (1922) observed a steady 
increase in motility through the second to third dayls 
starvation, followed by a steady decrease thereafter.
Siegel and Steinberg (1949) subsequently studied 
60 rats in four groups deprived of food for 12, 24, 36 
and 48 hours respectively. Activity was measured in 
"home cages" fitted with a phototronic relay system.
All privation intervals resulted in a significant increase 
in mean activity compared with no privation.
Bryan and Carlson (1962), attempting to replicate 
the above findings in 7 adult men, reported no correlation 
between food deprivation and "spontaneous activity". They 
employed an open field test in which the floor of a room 
was divided into squares; activity scored by an observer 
counting the number of squares entered by a subject during 
each of 2 daily 15 minute test periods. Food deprivation
was continued for a minimum of 89 hours. Two of the seven
7subjects were randomly selected to serve as controls.
In view of this flaw in study design alone it is perhaps 
not surprising that "comparison of the control and 
experimental groups failed to demonstrate significant 
differences in spontaneous activity". However, the 
methodology of this study also illustrates, in my view, 
the problem of isolating primitive drive behavior in 
the conscious adult human subject. This population 
had contracted not to eat for a period of time in exchange 
for money. Presumably they did experience stomach contract­
ions during starvation, however their awareness may have 
altered the logic of the simple correlations found previously. 
These subjects were aware that body movement would not have 
resulted in food-getting. A measure of motility in sleep 
- characterized by its diminished awareness - might have 
been a more appropriate index of "spontaneous" activity 
in these subjects.
The effects of relative food intake on several indices 
of arousal were investigated recently by Christie and 
McBrearty (1979) in a study of "postprandial lassitude".
Body temperature, heart rate, palmar skin potential, 
capillary blood glucose, mood and performance were measured 
post-lunch and post no-lunch in 20 adult male and female 
subjects. This is a confused study, in my view, written 
in an unnecessarily obscure style. However, the authors® 
attempt to isolate psychobiological factors underpinning 
tiredness after eating is pertinent to the present hypo­
thesis and their results are therefore included for 
evaluation.
8Testing of the various parameters was carried out 
at intervals between 1200 and 1700 hours. Baseline 
values for all indices were determined before either a 
meal or coffee alone were presented at 1300 hours. Each 
subject was tested on the same day of two consecutive weeks, 
with balanced treatment order. Within the subject group 
there were no significant sex differences in age, smoking 
behavior, extroversion or neuroticism scores, or normal 
food intake patterns. Females were all tested in the low 
hormonal phase of the menstrual cycle. No information 
was given as to the specific constituents of the experim­
ental meal; nor were data on subject weights or BMR 
available. It is assumed that a standard meal was given 
to all subjects.
Study results:
1. Deep Body - but not Oral - Temperature was 
significantly higher post-lunch compared with post no-lunch, 
peaking sharply at 1400 hours thereafter falling sharply
to pre-lunch values at 1700 hours. There was a signific­
ant effect of sex, females exhibiting higher Deep Body 
Temperature post-lunch than males.
2. Palmar Skin Potential showed the usual gradual
diurnal increase toward evening in all subjects independent 
of treatment, or performance testing versus rest. Within 
this normal variation, however, the following significant 
interactions emerged: a) there was a marked increase in
skin potential during performance tasks at 1415 hours post 
no-lunch versus post-lunch; b) male skin potential showed
9a decrease post-lunch compared with post no-lunch, while 
female values showed the opposite response.
3. Heart rate. During rest, mean male pulse
rate increased significantly post-lunch versus post no­
lunch. Mean female pulse rate was significantly higher 
than male values for both conditions and did not alter
as a function of eating lunch. Male pulse rate was lower 
than female in all conditions of rest and task performance.
4. Blood Glucose values rose significantly post­
lunch compared with post no-lunch in all subjects.
5. Mood, as assessed by the Nowlis Mood Adjective 
Check list, showed a significant increase in "deactivation" 
in all subjects post-lunch, which surpassed pre-lunch levels 
at 1700 hours sampling. Post no-lunch, all 20 subjects 
showed a decrease in "deactivation", followed by a sharp 
increase at 1600 hours sampling.
6. Performance. Females showed no significant
difference in performance (letter cancelling task) post­
lunch compared with post no-lunch. Male subjects showed 
a significant post-lunch decrease in cancelling compared 
with an increase in the post no-lunch condition.
Thus, all subjects demonstrated significantly increased 
blood glucose levels and deep body temperature and a 
"deactivation" of mood after eating. Skin potential, heart 
rate and performance measurements showed more variation 
within the population, correlated with sex.
10
Christie and McBrearty summarize their unexpected sex-
linked findings as follows:
"Males relaxed more easily in the post-lunch 
condition, as well as increasing their pulse 
rate and showing deficits in cancelling per­
formance. Females, however, showed a reversal 
of trend: they relaxed less easily after lunch,
showed no significant differences between post­
lunch and post no-lunch pulse rates, and no 
deficit in performance."
Christie and McBrearty suggest that 1omission of lunch 
on one occasion only may be followed by a conditioned response 
to the customary meal, and hence no adequate control for post 
prandial data*. However, as they also point out, their 
blood glucose data did reflect the fasting state ’thus there 
seems to be an afternoon change of state determined by lunch­
time intake, and not solely by a nadir in a 12 hour wakefulness 
cycle'.
This study further illustrates, in my view, the difficulty 
in assuming an holistic model of arousal response, certainly 
in conscious adult human subjects; i.e. that the hypothesized 
effect of primitive drive cycles will necessarily obtain at 
every level of every individual’s biological organization.
As in the Bryan and Carlson study quoted previously, the simple 
correlations found elsewhere between hunger and increased 
arousal and satiety and decreased arousal, may be reorganized 
within a more complex environment requiring more complex 
responses of an organism capable of them.
Sleep has been seen as a potentially fruitful arousal 
phenomenon for study, in that it may represent an elaborated 
form of rest in an evolutionary sense; is characterized by 
diminished awareness; and may, as a result, allow for the 
examination of primitive drive cycles otherwise obscured 
during wakefulness.
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Arousal effects of the presence or absence of normal 
food intake have been further investigated in the following 
studies of starvation and human sleep. Karacan et al (1973)
recorded the EEG sleep of 11 adult males on two occasions of 
67 hours fasting. During the first of the two occasions 
blood sampling for growth hormone (hGH) was included. They 
confirmed their hypothesis that fasting was associated with 
an increase in Stage 4 sleep, and in Stage 4-related hGH 
release. As growth hormone is known to be involved in the 
regulation of protein synthesis, and Stage 4 is considered 
the 'deepest*, slow-wave form of sleep, these findings may 
be taken to support the theory that slow-wave sleep (SWS) 
functions to promote body growth and repair. No figures 
for motility in the night were given. Taking the three 
nights undisturbed by blood sampling, there was no significant 
difference in the number of awakenings on fast nights com­
pared with baseline recordings; nor did sleep efficiency 
(% total sleep time (TST)/sleep period time) differ between 
the two conditions. The latter is difficult to interpret, 
however, as although mean TST was considerably reduced on 
the second night (401 - 27 minutes) compared with baseline 
(422 - 33 minutes), so were both time in bed (417 - 17 minutes
versus 435 - 31 minutes, respectively) and sleep period time 
/ + +(407 - 27 minutes versus 428 - 31 minutes respectively).
The effects of acute starvation were also examined in 
10 normal young men byMacFadyen et al (1973). Their methodo­
logy included a well-balanced design in which “two adaptation 
nights preceded four baseline nights, followed by four nights 
during starvation and four refeeding nights, all consecutive". 
SWS (Stages 3 and 4) was again found to be significantly
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increased during starvation as opposed to either baseline or 
refeeding nights. The only other sleep parameter to vary 
significantly was Stage REM in which a decrease during 
starvation was interpreted as a general and non-specific 
effect of stress. No figures for movement time or restless­
ness in the night were given, however mean total sleep 
duration was noted to fall as starvation progressed. The 
authors also reported a trend toward depression, anxiety and 
poor concentration in their subjects during fasting, along 
with complaints of faintness and headaches.
Measuring EEG arousal in food deprived rats,, Jacobs 
and McGinty (1971) reported a sharp decline in both REM and 
NREM sleep stages, beyond the 6th to 9th day of fasting.
Work by Siegel (1975) has suggested that REM sleep may 
be significantly related to normal food intake in the cat.
He found REM sleep time in a 12 hour period to be an accurate 
predictor - negatively correlated - of the amount of food 
eaten in the subsequent 12 hour period by 4 out of 5 cats 
fed ad lib. REM phase proved a better predictor of food . 
intake in these animals than either waking, SWS or previous 
food intake.
More recently Danguir and Nicolaidis, working with rats, 
have also reported significant correlations between sleep 
and feeding patterns. They found daily SWS and PS to be 
significantly increased during hyperphagia in ventromedial 
hypothalamic lesioned rats as compared with normals (Danguir 
and Nicolaidis, 1978a). In a subsequent study of sleep during 
4 days food deprivation and 3 days following food restitution, 
they reported dramatically decreased SWS and PS in lean 
animals during deprivation, with significant rebound of both 
stages associated with refeeding (Danguir and Nicolaidis, 1978b).
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They further reported (Danguir and Nicolaidis, 1979) signifi­
cant positive correlations between meal size and the amount 
of time spent in SWS and PS in the two subsequent inter meal 
intervals in normal animals.
2.b) Alterations in arousal (mood states, motility levels, 
sleep patterns) and food intake (anorexia, bingeing, weight 
loss/gain) have been suggested to co-vary symptomatic of 
various clinical disorders.
"Periodic somnolence and morbid hunger" - the 
so-called Kleine-Levin Syndrome - has been reported to 
occur exclusively in males, who present with "attacks of 
sleepiness lasting several days or weeks, associated with 
excessive hunger, motor unrest and various psychological 
features, notably irritability, mild confusion, incoherent 
speech and, at times, hallucinations" (Critchley and Hoffman, 
1942).
The Pickwickian (Burwell et al, 1956) or Sleep Apnea 
(Guilleminault and Dement, 1978) syndrome refers to a 
condition in which a degree of overweight and excessive 
sleepiness accompany respiratory insufficiency.
Crisp and Stonehill (1973), in an in-depth question­
naire "Study of 375 Psychiatric Outpatients", reported a 
relationship between weight loss and reduced TST, more broken 
sleep and early waking on the one hand, and weight gain, 
longer TST, no broken sleep and later waking on the other. 
These relationships transcended diagnostic categories.
Their date indicated no direct relationship between weight 
change and sleep latency, which was found to vary more as a 
function of mood.
Confirming previous reports of impaired food intake 
and low body weight associated with hyperactivity and insomnia
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in anorexia nervosa (Crisp, 1967; Crisp et al 1971), Lacey 
et al (1975) investigated EEG sleep in 10 anorectics before, 
during and after refeeding. The 9 women and one man studied 
all had a pre-treatment dietary pattern of abstaining; that 
is, severely restricted food intake - especially carbohydrate - 
as opposed to chaotic bingeing and vomiting. Treatment con­
sisted of a 3,000 Kcal/day balanced diet within a regimen of 
limited activity, individual and family psychotherapy. Weight 
gain was thus held to 1.1-1.6 kg/week until target weight, 
calculated from matched mean population tables for height at 
age of onset of the illness. Weight restoration was 
accomplished over a mean of 3.3 months. Sleep recordings 
were made on three occasions: on admission, at 15% below
target, and at target weight. Findings indicated that sleep 
changes corresponded to two distinct phases of weight gain.
On admission a gross reduction in both slow wave and REM 
sleep was found, associated with increased restlessness and 
reduced TST. Initial weight gain (to minus 15% target) was 
associated with increased TST, largely SWS plus some REM 
stage. During the final phase of weight gain, REM sleep 
showed a selective increase as SWS declined to normal values.
The sparse sleep and activity data for obese subjects 
losing weight are more equivocal, consisting largely of self- 
reports and conflicting evidence. Crisp and Stonehill (1970) 
observed no clear relationship between weight loss, daytime 
activity (pedometer scores) or TST in 3 in-patients, but 
observed activity levels to be increased during periodic 
complaints of insomnia. In a second report Crisp et al
(1973) 4 obese patients were investigated during weight 
loss by means of subjective sleep ratings and objective 
nocturnal motility readings. During four months of
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steady weight loss, the patients* reports - averaged - showed 
a reduction in TST from 7 hours 20 minutes in the first month 
to 6 hours 15 minutes in the fourth month; however, the authors
noted "...........  a wide range of response between patients
in sleep reports .......  " Reported duration of broken
sleep paralleled the nocturnal motility patterns of these 
patients, showing a decrease in the first month, followed by 
an increase to original levels in months 2, 3 and 4. In one 
subject, sleep EEG was recorded for two nights on each of 4 
occasions during 32.7 kg weight loss. TST did not vary in 
the course of weight loss. However, Stage 2 was found 
progressively to increase at the expense of Stage 4.
Nocturnal motility scores dropped sharply in month 2, there­
after increasing steadily. The above observations are in the 
nature of clinical assessment, as no statistical tests were 
reported for these data.
Several correlations between stable relative weights 
and sleep parameters have also been reported. Analysing 
20 sleep recordings from each of 16 subjects, Adam (1977a) 
found body weight significantly related to % REM sleep, and 
log body weight to mean total minutes REM,positively corre­
lated. She found no correlations between body weight and 
other sleep parameters, including TST and SWS. Inter-species 
comparisons in mammals have revealed metabolic rate to be 
inversely correlated with sleep cycle length (Zepelin and 
Rechschaffen, 1974). Since - as the author notes - log 
body weight is known to correlate highly with daily metabolic 
rate, the above results suggested a possible intra-species 
correlation as well. In a subsequent article based on the 
same data (Adam, 1977b) % deviation (overweight) from ideal
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body weight was reported to be positively correlated with 
mean sleep cycle length- Mean TST was found to be similarly 
correlated with both % deviation ideal body weight and mean 
sleep cycle-length.
In the Danguir and Nicolaidis work on rats, reported 
previously, the significance of weight for relationships 
between sleep and feeding patterns was further suggested.
While starvation correlated with reduced sleep and refeeding 
with increased sleep in lean rats, the correlations did not 
obtain in obese and VMH lesioned obese animals (Danguir and 
Nicolaidis, 1979).
3. The following studies have sought to explore the impact 
of specific foodstuffs - both chronic and acute - on various 
indices of arousal.
Stanley and Teschler (1932) recorded movement in the 
night in 7 male adults following each of four experimental 
conditions: nothing taken on retiring; a bedtime snack of
4 oz of cake; 4 oz eggs or meats; or one ounce of butter
on toast. The subjects were recorded for 10 days in each 
condition; treatment order was not balanced. It can only 
be assumed that subjects ate normally apart from the bedtime 
snacks. The lowest number of movements occurred after 
nothing was taken on retiring. Of the three snacks, protein 
was associated with most movement in the night, carbohydrate 
with least.
Giddings (1934) recorded sleep motility in 24 children 
between the ages of 9 and 14 years under a series of different 
dietary conditions. He found 6 oz warm milk taken on 
retiring effective in reducing motility in 41.7% of the 
children, whereas no consistent effect was associated with
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equivalent amounts of cold milk, warm or cold water, or 
beverages containing sucrose, or sucrose and caffeine.
In a further study comparing normal, light and heavy evening 
meals, the latter (consisting of fruit, meat, two vegetables 
and dessert) was associated with increased sleep motility 
in 23 out of 24 children. Virtually no difference in 
number of movements was found comparing the light meal 
(bread, butter and milk) with "normal" (fruit, cereal or 
eggs, bread, butter and milk).
Laird and Drexel (1934) also studied movement during 
sleep in 8 young adult males and 8 school children 
following one of two experimental evening meals: 1) an
"easy to digest" meal consisting principally of cornflakes 
and milk, or 2) a "hard to digest" meal made up of foods 
"slow to digest, producing flatulence, and diuretic foods". 
All subjects moved less frequently during sleep.after the 
"easy to digest" meal and more frequently than normal after 
eating the "hard to digest" foods. The results were most 
apparent in the first half of the night and particularly 
noticeable in the children.
The effect of a bedtime snack on sleep motility in 36 
adult males has been studied more recently by Hamilton et al
(1966). Again employing an apparatus designed to record 
bedspring movement, they found no significant difference in 
the frequency of body movements after a 275-calorie bedtime 
snack of cornflakes, sugar and milk compared with no snack. 
Subjective sleep quality estimations were found to vary 
independently of either snack/no-snack or sleep motility.
A series of studies has sought to test the popular 
notion that a bedtime snack of Horlicks, the proprietary
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cereal drink prepared with hot milk, improves sleep. As 
has been widely noted (Brezinova and Oswald, 1972; Iversen 
and Mackay, 1972; Adam, 1977c) such studies present major 
methodological problems of a kind both general to diet/sleep 
studies (eg distinguishing impact/ of daily dietary intake 
from experimental variable; defining improved sleep), and 
specific to investigations of Horlicks itself (eg controlling 
for subjects' expectation of product widely - advertised to 
promote good sleep;, finding appropriate placebo preparations). 
The following work reflects increasing attempts to refine 
methodology along these lines.
Thus, Southwell et al (1972) found a reduction of small 
body movements in the latter half of the night in four 
subjects after Horlicks as opposed to hot water. Brezinova 
and Oswald (1972) used electroencephalographic recordings 
to compare Horlicks with an inert capsule suggested to 
contain "a folk remedy of doubtful efficacy". They reported 
fewer transitory changes in EMG activity at the end of the 
night after Horlicks in a group of 10 young adults.
Reasoning that the more broken sleep characteristic of ageing 
would allow greater scope for their hypothesized effect, the 
authors repeated the comparison in 8 older adults, mean age 
55 years. In this group, they found sleep after Horlicks 
was of longer total duration and less broken by periods of 
wakefulness, again particularly late in the night, and that 
these effects increased with repeated administration.
Adam (1977c) subsequently investigated the effect of 
Horlicks on the EEG sleep of 10 older adults during 6 
nights under each of the following conditions: baseline;
early food drink; late food drink; withdrawal. She
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found no significant differences in the sleep of her subjects, 
comparing the four conditions. Adam (1977c) conducted a 
further study in 16 older adults introducing dietary restriction 
after 1700 hours, as had Brezinova and Oswald, in an effort to 
isolate any influences on sleep of four experimental variables:
1) placebo capsule; 2) a flavoured hot drink, calorically and 
nutritionally equivalent to Horlicks; 3) whole milk, taken hot;
4) Horlicks drink. None of the three food drinks was found 
to have a significant effect on sleep compared with the placebo 
capsule, although Horlicks was associated with significantly 
less broken sleep than either of the other two food drinks.
Neither did subjective ratings of sleep quality differ signif­
icantly among the conditions. In an interesting post-hoc 
treatment of the data, the importance of individual dietary 
habit was suggested such that in subjects who were accustomed 
to eating in the late evening at home, the laboratory continuation 
of this habit in the form of either milk or Horlicks was 
associated with "better" sleep - defined objectively - than 
was the change of habit represented by the placebo capsule.
A less striking reverse trend was also noted. Neither of 
these observations was statistically significant.
Total change of diet has been studied in relation to 
arousal in three ponies by Dallaire and Ruckebusch (1974), 
who monitored EEG sleep during three consecutive nights, 
after adaptation to one of three feeding regimens: 1) normal - 
hay and water ad libitum; 2) fasting - water only (2—5 days);
3) alternative foodstuff - oats equivalent in total energy 
to replaced hay and water. They reported parallel increases 
in REM and NREM sleep during both fasting and substitution of 
oats for hay. TST was found to be increased at the expense 
of drowsiness in these animals, as opposed to alert wakefulness.
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The "Sleep-Inducing Effect of a High-Protein Diet on 
Sheep" has been reported by Ruckebusch and Gaujoux (1976), 
who induced positive nitrogen balance in two animals by 
injecting varying amounts of coating urea and starch into 
the rumen. They were thus able to record a transition 
effect on sleep of low-protein to high-protein "diet", 
irrespective of ingested energy supply, which was found not 
to alter in either animal throughout the experiment. Their 
sleep data demonstrate a progressive and significant increase 
in both REM and NREM phases during nitrogen supplementation.
Sedative effects of fat have also been reported (Fara 
et al 1969). Introduction of milk or corn oil into the cat 
duodenum evoked: 1) an increase in superior mesenteric blood
flow (blocked by atropine) unaccompanied by changes in pulse 
rate, arterial pressure or iliac blood flow? 2) an inhibition 
of gastric and duodenal motility? 3) sedation. The latter 
was demonstrated both behaviourally and electro-physiologically, 
such that in the active awake animal drowsiness occurred; in 
the already drowsy animal a transition to slow-wave, high voltage 
sleep was seen; and in the animal asleep, REM episodes of 
markedly augmented frequency and duration were recorded within 
an hour of introduodenal injection. Duration of the changes 
was proportional to the amount of oil injected. Injection 
of milk into the stomach produced no detectable effect.
Fara et al reasoned on the basis of their results that 
fat-induced release of gut hormone cholecystokinin-pancreozymin 
(CCK-PZ) might play a role in the central sedating effects 
they observed. In a follow-up study, Rubenstein and 
Sonnenschein (1971) explored possible mechanisms for such 
effects. They found: 1) a 15% increase in TST usually
associated with an increased number of REM episodes in 3 cats
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following duodenal injection of 2 ml corn oil; 2) a 9% 
increase in TST/ always with increased number and frequency 
of REM episodes in 3 cats following a single large meal 
(Purina cat pellets), when compared with a fasting recording 
(12 hours food deprivation) immediately previous; 3) three 
cats subjected to gut denervation showed significantly 
reduced TST - including mean REM duration - during fasting, 
compared with controls. Both sleep parameters increased 
markedly following a single large meal but remained signi­
ficantly below normal levels; 4) after four hours fasting, 
i.v. infusion of secretin and CCK in 3 cats induced SWS 
and longlasting REM episodes after 10-25 minutes.
In the light of the above results, I am interested to 
note findings by Gibbs et al (1976) of large, rapid, dose- 
related suppressions of feeding following i.v. CCK infusion 
in five rhesus monkeys after overnight food deprivation. 
Equivalent suppressions were also observed on infusion of 
either a synthetic preparation of the active portion of the 
CCK molecule; or the amino acid L-phenylalanine, a potent 
CCK releasor. No such effect was associated with infusion 
of D-phenylalanine, a weak CCK releasor. Unfortunately, 
no other measures of arousal - autonomic, behavioural, 
electroencephalographic - were included in the Gibbs et al 
methodology.
Food deprived cats trained to press a lever on a 
variable interval schedule for milk reward displayed 
bursts of relatively large amplitude parieto-occipital 
spindling during consumption of the reward (Marczynski 
et al 1968). Such EEG synchronization correlated with 
conditioned rewards has been termed "post-reinforcement 
synchronization", or PRS (Roth et al 1967). In the 
Marczynski et al study, "When each lever press was rewarded,
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the parieto-occipital cortex displayed almost continuous 
spindle bursts whereas the somato-sensory cortex remained 
desynchronized. In trained subjects both milk or water 
produced identical PRS. However, when water was substi­
tuted for milk during the course of an experiment, PRS was 
completely suppressed and overt signs of "emotionality" 
appeared. Subjects allowed to drink milk from a bowl 
displayed a similar topographically restricted ECoG 
synchronization. Both types of consummatory ECoG 
synchronization were suppressed in darkness or by novel 
stimuli, and both were indiscernible from sleep-spindle 
ECoG activity recorded from the same region in satiated 
subjects, although during sleep the occurrence of spindles 
did not depend on the presence of light and their cortical 
distribution was more diffuse.
"...... The primary and secondary evoked potentials
recorded from various cortical projections during bursts 
of PRS were conspicuously augmented. Their amplitude, 
much greater than that recorded during relaxed wakefulness 
in satiated subjects, was comparable to that observed during 
spindle slow-wave sleep. The evoked potentials recorded 
after non-rewarded lever pressing, ie during desynchronized 
ECoG activity, were poorly developed; they were comparable 
to those observed during emotional excitement".
The authors suggested on the basis of their results: 
"(1) PRS is triggered by transient depression of RAS*; and 
(2) there is a functional overlap between reward centres 
and hypnogenic (ie synchronizing) influences."
Similar findings were published by Sterman and Wyrwicka
(1967) who reported PRS to be identical to sleep ECoG and
*Reticular Activating System
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that PRS occurrence depended "on the desirability of food 
reinforcement".
The impact on sleep of varying proportions of fat, 
carbohydrate and protein within 24 hour isocaloric diets 
of natural foods has been investigated in man by Phillips 
et al (1975). Comparing a normal balanced diet (350gC, 
140gF, 75gP) with high-carbohydrate/low-fat (680gC, 33gF, 
75gP) and low-carbohydrate/high fat (lOOgC, 255gF, 75gP) 
conditions in 8 young males, they found the high carbo­
hydrate/low fat diet associated with significantly less 
SWS than either of the other two. They reported both 
experimental diets, but especially the high-carbohydrate/ 
low fat, to correlate with significantly increased REM 
sleep compared with the normally proportioned diet. These 
relationships emerged despite a design flaw in treatment 
order such that potential adaptation effects could not be 
directly assessed. However, taking all the treatment 
effects into account, it is difficult to explain the 
correlations derived on the basis of laboratory adaptation 
alone: for example, the hi-CHO/low fat related decrease
in SWS; and the significantly greater increase in REM 
sleep after hi-CHO/low fat compared with low CHO/hi-fat 
intake.
Lacey et al (1978) have sought to test the immediate 
impact of amino acids and glucose on the sleep EEG of 9 
young women, via all-night i.v. infusion. Daily diet was 
kept constant (normal, balanced). A litre of either 
saline, a 5% glucose, or an amino acid solution was given 
simultaneously with EEG, EOG and EMG recording throughout 
the night in balanced treatment order. The amino acid
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infusion was found to be significantly associated with an 
increase in SWS when compared with saline, as was the 
glucose, to a lesser extent. A significant reduction in 
REM sleep during amino acid infusion was reported. TST 
was not found to vary with treatment. Indices of rest­
lessness in the night (sleep latency, intervening Stages 
0, 1 and movement time) tended to be increased with i.v. 
amino acids and decreased with i.v. glucose. These data 
did not reach statistical significance, but were confirmed 
by the subjects* self-reports of sleep quality.
Investigating the effect on sleep of intravenous nutri­
ents in the rat, Danguir and Nicolaidis (1980a)substituted 
lipid, glucose, amino acid or composite infusions for 
normal food intake. Daily caloric needs were supplied in 
this manner for 3 consecutive days in each condition. 
Continuous glucose or lipid infusion did not affect the 
daily sleep quotas. Amino acid infusion brought about 
a significant increase in PS whereas SWS remained unchanged. 
Infusion of the composite solution was associated with 
significant increases in both sleep stages. Interestingly, 
"the same increase in SWS and PS was observed when exogenous 
insulin was coinfused with continuous infusion of glucose 
or when glucose infusions were discontinuous".
4. Summary and Conclusions
In part, the evidence seems to suggest a relationship 
between hunger and increased arousal in various forms, and 
satiety and decreased arousal, as in Wada * s finding of a 
correlation between perceived hunger and increased stomach 
activity in the form of contractions; and, in turn, between 
stomach contractions and augmented body movement, motor
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aptitude and mental efficiency. Such a relationship was 
also observed by both Wada and Irwin in the cycling of 
infant motility around feeds. Richter's results in rats, 
along with those of Siegel and Steinberg, also suggest 
hunger to be associated with.increased arousal as measured 
by motor activity. Such an association is again suggested 
in the symptomatology of the Kleine-Levin, Sleep Apnoea 
and Anorexia Nervosa syndromes: and in the Crisp and
Stonehill questionnaire study of psychiatric outpatients.
In the more detailed investigations into sleep phases 
of circadian rhythms, reduced TST with progressive starva­
tion (Karacan et al, 1973: McFadyen et al, 1973: Jacobs
and McGinty, 1971) may be interpreted to support a hunger 
increased arousal correlation. The Danguir and Nicolaidis 
results further corroborate such a relationship, particularly 
as the reduction in sleep with food deprivation was demon­
strated to rebound on refeeding. The Jacobs and McGinty 
results may not be strictly comparable as they induced an 
advanced state of starvation in their rats not possible in 
human subjects. However, the Lacey et al (1975) findings 
in anorexics at pathologically low body weight are in 
agreement.
The correlation between temporary, voluntary fasting 
and increased SWS in the Karacan et al and McFadyen et al 
studies in humans may be interpreted, consistent with 
Oswald's sleep function theory, as one index of an organisms' 
capacity to adapt physiologically to the metabolic impair­
ment of zero energy intake. Similarly the lack of 
correlation between starvation and increased 'spontaneous 
activity' in the Bryan and Carlson study may reflect the
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subjects1 efforts to conserve energy within the terms of 
that experiment.
In the Christie and McBrearty study, there was some 
evidence of an association between hunger and increased 
arousal - physiology/ mood, performance - and satiety and 
decreased arousal, though not in every subject for every 
measure. I do not wish to speculate further on the 
possible significance of the sex-linked differences 
observed, but to suggest the conclusion that, particularly 
where consciousness and volition become factors in the 
study of drive behaviour, experimental parameters at 
different levels of biological explanation may co-vary 
inconsistently within the logic of a particular individual 
in a particular environment.
While the function of REM sleep, despite much 
theorizing, remains an enigma, correlations reported between 
quantity of food taken and amount of REM (Siegal, 1975) 
body weight and REM cycling (Adam, 1977b), and high carbo­
hydrate/low fat diet and increased REM (Phillips et al,
1975) imply its metabolic significance.
The data comparing specific foodstuffs with arousal 
levels suggest the following conclusions, in my view:
(1) That a decrease in arousal - less motility;
sedation; increased SWS - maybe associated with ingestion 
of nutrients (Giddings, 1934; Laird and Drexel, 1934; 
Southwell et al, 1972; Brezinova and Oswald, 1972;
Adam, 1977b; Dallaire and Ruckebusch, 1974; Ruckebusch 
and Gaujoux, 1976; Fara et al, 1969; Marczinski et al, 
1968; Roth et al, 1967; Sterman and Wyrwicka, 1967;
Lacey et al, 1975; Danguir and Nicolaidis, 1980).: How­
ever, in the Dallaire and Ruckebusch study, fasting was
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also associated with increased TST including drowsiness,
NREM and REM phases. The increased NREM sleep in this 
condition is consistent with previous findings cited in 
fasted human subjects (Karacan et al, 1973; MacFadyen et 
al, 1973). The Lacey et al (1978) data must be inter­
preted with caution in view of the invasive nature of i.v. 
infusion, particularly during sleep.
(2) That decreased arousal in association with eating 
may in turn be correlated with a number of factors:
a) There is some suggestion that habit (Stanley and 
Teschler, 1932; Giddings, 1934; Adam, 1977c) bulk/ 
digestibility (Stanley and Teschler, 1932; Giddings, 
1934; Laird and Drexel, 1934;) age (Giddings, 1934; 
Brezinova and Oswald, 1972); sex (Christie and 
McBrearty, 1980) may either enhance or mitigate post­
prandial decreases in arousal.
b) It may be inferred that the relative warmth of
the food ingested is a significant factor for subsequent 
lowered arousal in children (Giddings, 1934) but not in 
adults (Southwell et al, 1972; Adam, 1977c).
c) There may be a sedative effect, or cortical 
"post-reinforcement synchrony", associated with the 
achievement of a reward represented by eating desired 
foodstuffs (Marczynski et al, 1968; Roth et al, 1967; 
Sterman and Wyrwicka, 1967).
d) Relationships between feeding and sleeping patterns 
may be dependent on body weight (Adam 1977a,b,c; Danguir 
and Nicolaidis, 1979; Crisp, 1967; Lacey et al, 1975).
e) Where specific nutrients may be compared, protein 
(Ruckebusch and Gaujoux, 1976;, Danguir and Nicolaidis,
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1980), fat (Giddings, 1934: Fara et al, 1969) and
carbohydrate (Stanley and Teschler, 1932; Giddings, 
1934; Laird & Drexel, 1934; Southwell et al, 1972; 
Brezinova and Oswald, 1972; Adam, 1977c; Dallaire 
and Ruckebusch, 1974; Lacey et al, 1975; Danguir 
and Nicolaidis, 1980) have all been reported to 
correlate with lowered arousal. There is a suggestion 
that the relationship obtains most consistently with 
carbohydrate.
(3) Finally, I note these observations within the 
limitations inherent in comparison between species; and - 
within species - between differing experimental methodo­
logies, even where each may be valid in itself.
In conclusion, general inference of the significance
of food-intake for sleep may also be drawn from sleep 
investigations in phylo-genetically close relatives of 
pre- and early mammalian species (Allison and Van Twyver, 
1970). Such studies suggest that the minimal arousal 
of NREM sleep may have evolved in tandem with increased 
metabolic demands of homeothermy. The present work 
reflects speculation as to what correlates at the bio­
chemical level might have evolved to subserve the normal 
functioning of such an adaptation.
B. Work correlating diet, serotonin and sleep.
1. There is much evidence to suggest that variations in
precursor availability, within a normal physiological 
range, can affect synthesis of neurotransmitters in the 
brain. The transmitter 5-hydroxytryptamine (serotonin; 
5-HT) , derived from tryptophan, has been implicated in the 
induction and maintenance of sleep stages. It has been
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reported that changes in plasma tryptophan levels corres-
■)
pond to changes in brain 5-HT levels, and that dietary 
intake affects the composition of the plasma tryptophan 
pool.
2. a) Histofluorescent techniques reveal cell bodies 
of 5-HT containing neurons to be located largely in the 
raphe nucleii of the midbrain and upper pons (Dahlstrom 
and Fuxe, 1964; Pin et al, 1968; Ungersted, 1971).
Gross lesions of this area in cats were found to (i) 
decrease cerebral 5-HT; and (ii) produce almost total 
insomnia (Jouvet and Renault, 1966; Pujol et al, 1971). 
With moderate lesioning a limited amount of SWS, plus 
some stage REM, occurred.
Reserpine, which depletes 5-HT stores, has been 
reported to suppress slow wave sleep in cats (Matsumoto 
and Jouvet, 1964) and humans (Coulter et al, 1971), and 
to increase REM sleep in humans taking clinical doses 
(Hartmann, 1966; Hoffman and Domino, 1969; Coulter et 
al, 1971). However, high doses of reserpine have been 
found to "disrupt" REM patterns in cats (Delorme et al, 
1965).
PCPA, which blocks the first stage of 5-HT synthesis, 
was also reported to suppress stage REM in cats (Delorme 
et al, 1965), but to suppress slow wave sleep in monkeys 
(Weitzman et al, 1968). Two studies have reported total 
insomnia associated with PCPA administration in both cats 
(Delorme et al, 1966) and rats (Torda, 1969). However 
repeated PCPA doses in cats, associated with prolonged 
5-HT depletion, were reported to result in only transient 
insomnia (Dement, 1969). Pujol et al (1971) reported
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near total insomnia in 4 cats 12 hours after PCPA injection 
(500 mg/kg) which lasted 4-5 days after which both REM and 
NREM phases returned to control levels without rebound.
In two human cancer patients, repeated treatment with 
PCPA was found selectively to suppress REM sleep (Wyatt 
et al, 1969).
Weiss et al (1968) have reported a small but signi- 
cant fall in brain 5-HT levels in REM deprived rats, 
accompanied by a rise in 5-HIAA, its principal deaminated 
catabolite. Hery et al (1970), Stern et al (1971) and 
Cramer et al (1973) have demonstrated increased brain 
5-HT turnover with REM deprivation.
b) In contrast to the evidence cited above, the 
following studies have sought to assess the affect on 
sleep of increased brain 5-HT levels. The bulk of such 
work involves relatively indirect manipulation of serotonin 
metabolism - as presently understood - as the monoamine 
neurotransmitters cannot cross the blood/brain barrier.
Direct intracarotid injection of 5-HT has been 
reported to induce "a protracted phase of (EEG) hyper- 
synchrony" in cats (Koella and Czicman, 1966).
Depressed patients, during treatment with a monoamine 
oxidase inhibitor, were reported to have increased total 
sleep, including decreased sleep latency, reduced number 
of awakenings in the night, and increase slow wave and 
REM phases (Cazzulo, 1969).
Mice receiving high doses of nicotinamide - which 
may increase brain 5-HT levels by suppressing pyrrolase 
activity - showed significantly more REM sleep than a 
control group receiving saline (Beaton et al, 1974).
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Injection of LSD-25 - reported to increase brain 5-HT and 
decrease brain noradrenaline levels - was associated with 
increased REM sleep and decreased sleep cycle length in 
the rat (Hartmann, 1967).
5-hydroxytryptophan, intermediate in the conversion 
of tryptophan to serotonin, has been reported to have a 
paradoxical, dose-related effect on arousal in animals 
such that low doses were associated with sedation and 
high doses with excitation (Monnier and Tissot, 1958;
Bogdanski et al, 1958; Erspamer, 1961). In the Delorme 
et al (1965) study cited previously, the disruption of REM 
sleep reported with high doses of reserpine or PCPA was 
reversed on administration of small amounts of 5-HTP.
Similar findings have been reported in man (Wyatt et al,
1969; Wyatt et al, 1970a). Pujol et al (1971) reported 
that in their PCPA-treated cats, 5 mg/kg 5-HTP administered 
at maximal insomnia (40 hours post PCPA injection) restored 
both REM and slow wave sleep to normal levels for 6 hours, 
after which relative insomnia recurred. 40-50 mg/kg 5-HTP 
restored normal sleep for 12 hours. The low 5-HTP dose 
in normal cats had no significant effect on either EEG or 
behaviour. The high dose in normals was associated with 
a brief period of nausea; sleep posture; and a period 
of abnormal sleep, ie cortical and subcortical slow waves 
and an 8-hour suppression of REM sleep followed by a 
rebound 30% above control levels.
Increasing doses of i.v. 5-HTP (50-150 mg) in a 
single human subject were reported to progressively 
increase REM sleep (Mandell et al, 1964). Oswald et al, (1966) 
have reported a shortening of REM latency in a patient 
receiving 40 mg i.v. 5-HTP.
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Studying the effects of 600 mg 5-HTP taken orally in 
the evening by 6 normal subjects, Wyatt et al (1970b) 
reported a significant increase in REM sleep and a signi­
ficant decrease in NREM sleep. In a further study of 
12 normal subjects taking 200, 600 and 800 mg oral 5-HTP. 
Wyatt et al (1971c) again observed increased REM sleep, 
although unrelated to dose, and increased REM density.
They reported a "slight decrease" in NREM sleep.
Zarcone et al (1973) reported increased REM sleep 
and decreased NREM sleep in normal subjects following 
oral 5-HTP (200-600 mg) taken in the evening. In a 
second study, following daytime ingestion of a total of 
2,500 mg 5-HTP, they observed an increase in REM efficiency, 
and a reduction in the number of stage changes throughout 
the night. Stages 3 and 4 were found to increase on 
recovery nights. These authors also reported increased 
REM and REM density in two schizophrenic children treated 
with 5-HTP. Paradoxically, they describe a therapeutic 
effect of oral 5-HTP in a narcoleptic with cataplexy, 
accompanied by a reduction in both % REM, and the number 
of stage changes from wakefulness to REM. Finally they 
observed increased REM efficiency in a group of alcoholics 
treated with oral 5-HTP.
The amino acid L-tryptophan was observed 20 years 
ago to have "sedative qualities" (Oates and Sjoerdsma,
1960), since when its hypothesized role as "natural hypnotic" 
has been widely investigated.
Oswald et al (1964) reported abnormally early REM 
onset (i.e. less than 45 minutes after the first sleep 
spindle) in 4 of 12 normal young men who ingested 5-10 g 
L-tryptophan on retiring.
Williams et al (1969), investigating the effect of
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7.5 g L-tryptophan on the sleep of 11 subjects, found the 
amount of SWS significantly increased over baseline and 
placebo levels. Percent time awake declined with tryp­
tophan, as did sleep latency and the frequency of body 
movements. Percentage REM was found to vary unsystem­
atically around baseline values• however, both REM latency 
and REM density were consistently reduced.
Wyatt et al (1970c) compared the effects of 7.5 g 
L-tryptophan with 7.5 g placebo powder mixed with a milk­
shake taken at bedtime in 5 female patients and 5 
insomniacs. In both subject groups, tryptophan was 
found to be associated with an increase in NREM sleep.
In the normals this was accompanied by a decrease in 
stage REM, while in the insomniacs TST was also increased. 
The authors also report that L-tryptophan produced signi­
ficant increases in NREM and decreases in REM sleep when 
given to 3 cancer patients whose REM had been severely 
suppressed in association with PCPA therapy.
Hartmann has conducted a series of studies investi­
gating the sedative effects of L-tryptophan. He com­
pared sleep patterns in 7 rats under baseline (normal 
diet) and tryptophan-free diet conditions, reporting 
increased sleep cycle length, mild sleep disturbance and 
slightly reduced TST with tryptophan deprivation. In a 
similar study of 4 tryptophan-loaded rats (2.5 g L- 
tryptophan per 100 g of diet, resulting in about 36 times 
normal tryptophan content)Hartmann reported decreased 
cycle length in addition to mild sleep disturbance and 
slightly decreased TST associated with the tryptophan 
load (Hartmann,1967). Hartmann subsequently reported
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(1970) that 5-10 g tryptophan significantly reduced mean 
sleep latency in ten normal human adults. In a study 
of 24 insomniacs (1971)/ his group observed a 4-5 g dose 
of tryptophan to be effective in increasing TST and 
decreasing both sleep latency and wakefulness in the 
night. Comparing varying doses (1,2, 3,4, 5, 10 and 
15 grams) of L-tryptophan with placebo in 10 normal men 
(1974), Hartmann et al observed a significant reduction 
of sleep latency with all tryptophan doses. With the 
higher doses only (10-15 g), a decrease in REM sleep, 
and an increase in SWS was reported. Single night sleep 
recordings were subsequently carried out by Hartmann and 
Elion (1977) in 42 young adults. The subjects were 
divided into three equal treatment groups, the first 
receiving a placebo capsule on retiring; the second,
1 g L-tryptophan; the third, 3 g L-tryptophan. Despite 
the hypothesized sleep disruption of laboratory "first 
night effect", both tryptophan groups had shorter sleep 
latencies than the placebo group.
Mendels and Chernik (1972) studied the effects of 
oral L-tryptophan and L-tryptophan plus pyridoxine on 
sleep in 4 psychiatric patients and 4 normal controls.
It has been reported that pyridoxine may increase the 
conversion of L-tryptophan to 5-HT (Berman et al, 1969). 
The authors concluded: "L-tryptophan increased actual 
sleep and decreased wakefulness in all subjects studied. 
However, with the exception of this general hypnotic 
effect, the findings are not striking or consistent".
Griffiths et al (1972) have reported qualitatively 
different, dose-related effects of L-tryptophan on sleep.
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They compared sleep recordings after 7.5g L-tyrptophan 
taken in apple sauce at bedtime, with baseline and 
recovery recordings (after apple sauce only) on 13 young 
adult males. The study was not double blind as the 
apple sauce did not mask the bitter taste of the amino 
acid. This "moderate dose" of tryptophan was associated 
with subjective reports of extreme drowsiness; reduced 
wakefulness in the night; reduced REM latency and sleep 
cycle length and increased SWS. In a second experiment 
8 young males ingested 12g L-tryptophan according to a 
similar design, this time adopting a bitter chocolate 
preparation which allowed for double blind conditions.
The "high dose" of L-tryptophan was associated with 
subjective drowsiness, reduced sleep latency, and increased 
percentage REM.
Clancy et al (1978) compared sleep patterns in 24 
rats, 12 of which were chronically maintained (minimum 
12 weeks) on a specially prepared diet calculated to be 
50% tryptophan deficient. The 12 controls were fed a 
normal laboratory diet. Their results revealed no 
significant differences between the tryptophan deficient 
and sufficient animals in time spent awake, slow wave 
sleep or REM sleep.
Nicholson and Stone (1979) examined both daytime and 
night-time sleep characteristics in six healthy male 
volunteers after ingestion of placebo or varying doses of 
L-tryptophan in random order, under double blind conditions. 
For the daytime recordings 1, 2 and 4 grams of tryptophan
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were examined; for the night-time experiments, 2, 4 and 6 
grams. The authors reported possible diurnal rhythm 
and dosage effects such that in the night-time studies,
4 grams of tryptophan were associated with reduced - 
awakenings in the night, increased Stage 3 sleep and 
increased %REM when compared with the placebo and other 
dose conditions taken together. In the daytime record­
ings , the 4 gram dose was associated with increased Stage 3 
when compared with placebo alone.
Daytime effects of intravenous L-tryptophan infusion 
in normal subjects have been reported by Greenwood et al
(1974), who compared doses of both 75 and 100 mg/kg with 
normal saline. A significant increase in EEG slow wave 
activity (4.0 - 7.5 Hz), and a trend towards decreased 
fast-wave activity (13.5 - 26.0 Hz) was found associated 
with the tryptophan infusions as compared with saline.
No differences between the two doses of tryptophan were 
found, however. Subjective ratings showed reduced arousal 
and increased drowsiness with tryptophan.
Hartmann has been the most active proponent of tryptophan 
as a ’natural hypnotic1 and much of the case for its role in 
sleep rests with his work. He has conducted studies in well 
over 200 subjects in addition to animal work. He has 
reported associations between tryptophan and sleep stages, 
including 1D-time1 or REM sleep, slow wave sleep and wake­
fulness in the night, as well as Total Sleep Time and sleep
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cycle length. His most consistent reported finding has 
been of reduced sleep latency with tryptophan. However, 
as with other researchers, these associations have not been 
consistently replicated, sometimes being reported with low 
doses of < 1.0 - 5.0 grams, sometimes with loading doses 
of 5.0 - 15.0 grams; on some occasions not at all. Correl­
ations found in one population are not consistently found 
in another.
Such inconsistencies are not unusual in clinical 
research , and the opportunity to develop a hypnotic drug on 
rational rather than empirical grounds is attractive. 
Hartmann concludes from his work that tryptophan can be 
an effective natural hypnotic. To what extent is his case 
justified?
In Hartmann's early study in rats cited above (Hartmann, 
1967), the major finding was of increased sleep cycle length 
under the tryptophan-free diet condition and decreased 
cycle length with the excess tryptophan diet. No other 
sleep variables were found to correlate with the diet con­
ditions. The numbers'of animals used were small: seven
rats in the tryptophan-free diet and only four in the sup­
plement diet, with only nine recording periods reported for 
the week in which the rats were eating the supplement diet. 
The author also noted non-significant trends towards mild 
sleep disturbance and decreased Total Sleep Time on both 
diets. This observation is inconsistent with the hypothe­
sized role of tryptophan and the interpretation of these 
data is therefore unclear.
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The next study cited (Hartmann, 1970) reporting 
significantly reduced sleep latency in 10 normal adults 
with doses of 5 - 10 grams of tryptophan, is based on a 
total of 63 placebo nights and 38 tryptophan nights, an 
adequate sample. The mean sleep latency with placebo was 
17.1 minutes as compared with 9.8 minutes in the tryptophan 
condition, a significant difference of p<0.01. However 
these results are based in part on unpublished dats, so it 
must be assumed that the method was experimentally sound.
In any case, the data were not broken down for the different 
doses administered. Total Sleep Time and Stage REM were 
also significantly increased in the summarized tryptophan 
conditions (but only at the 0.05<p<0.01 level), which the 
author interprets as showing that sleep stageing and distri­
bution were not greatly affected, whereas most hypmotics 
are known to suppress REM sleep. While the sleep latency 
finding stands out in these data, the method cannot be 
properly examined.
In his study of 24 chronic insomniacs (Hartmann, 1971), 
Hartmann presented detailed data comparing placebo and 2, 3, 
4, and 5 gram doses of tryptophan taken at bedtime. Sleep 
was not polygraphically recorded, but assessed by an observer 
circulating through the ward at 15 minute intervals through­
out the night. Only the- two higher doses of tryptophan 
were found to decrease both sleep latency and number of 
awake assessments significantly, although the differences 
were not large: a latency of 3.9 check periods with the
placebo compared with 3.2 each with 4 and 5 grams tryptophan.
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Total sleep and sleep percent estimates were also increased 
with the 5 gram dose compared with placebo. The authors 
noted a tendency for the sleep measures to improve over the 
two-week course of the study, although this should not com­
promise the findings as the different experimental conditions 
were administered randomly. The observer method of record­
ing sleep can have a validity of its own, and appears to 
have been appropriately applied in this well-controlled 
study. It is, however, a relatively coarse measure, par­
ticularly when distinguishing drowsiness form light sleep 
which has direct relevance for estimates of sleep latency.
In the next study cited of 10 normal males taking a 
wide range of tryptophan doses (Hartmann et al, 1974), the 
most consistent finding was again a reduction in sleep latency, 
compared with placebo. Each subject received on one occa­
sion each a dose of either 1, 2, 3, 4, 5, 10 or 15 grams of 
tryptophan. The recordings were made one night per week 
for a series of 12 weeks, randomly ordered. All of the doses 
with the exception of 2 grams, resulted in significantly 
reduced sleep latency although not in a stepwise manner, the 
1 gram dose appearing as effective as the larger doses.
The reduced waking time reported for the 1 and 4 gram doses 
is misleading, however, as the sleep latency was included in 
the estimate of waking time. The significant reduction in 
REM sleep with the 10 and 15 gram doses is difficult to explain 
viewing the data as a whole and may be a statistical ‘false 
positive1. Similarly the significance of increased Slow Wave 
Sleep with the 10 gram dose only is open to question.
35e
While the reduction in sleep latency overall is a consistent 
result in this study, I would have more confidence in the 
data if the laboratory schedule used had been defined.
The authors in fact point to the influence recording time 
may exert on sleep studies, but do not discuss this in their 
own methodology.
The final study cited of 42 college students recorded
for one night each is an interesting use of the laboratory
'first night effect1 to test the action of a drug
(Hartmann and Elion, 1977). The students were divided into
three groups matched for age, sex and reported sleep latency
and Total Sleep Time at home. One group received placebo.,
the other two 1 and 3 grams of tryptophan respectively,
under double blind control. The only sleep variable to
relate significantly to the tryptophan conditions was, again,
4.
sleep latency which was found to be 24 - 6.9 minutes in the 
placebo group, 14 - 2.7 minutes in the group taking 1 gram 
of tryptophan, and 15 - 2.9 minutes in the group taking 
3 grams tryptophan. Examining the raw data, however, it is 
clear that the significantly longer sleep latency in the 
placebo group was due almost entirely to that for a single 
out-lying subject, who had a sleep latency of 102 minutes.
In summary, while there is some evidence that tryptophan 
may reduce sleep latency in some subjects in some doses, the 
case for considering it a 'natural hypnotic', despite its 
role as the precursor to serotonin, is still to be proven.
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3. Diet, Tryptophan Metabolism and Serotonin
The inconsistent effects on sleep parameters of 
the serotonin precursors has focussed interst on mechan­
isms governing the tryptophan ^ 5-HTP ^ 5-HT
pathway. That brain 5-HT metabolism and concentration 
correlate positively with tryptophan intake has been 
widely reported (e.g. Green et al, 1963; Ashcroft et al, 
1965; Moir and Eccleston, 1968). Brain serotonin 
concentration in rats has been demonstrated to closely 
parallel normal daily fluctuations in plasma tryptophan 
levels (Fernstrom and Wurtman, 1971a). This has been 
suggested (Grahame-Smith, 1964; Eccleston et al, 1970; 
Fernstrom and Wurtman, 1971) to reflect the high Km of 
tryptophan hydroxylase, rate-limiting enzyme in the path­
way, which is calculated to be only half-saturated with 
substrate under normal physiological conditions.
Blasberg and Lajtha (1965) have described a specific, 
saturable amino acid carrier-system with a high affinity 
for tryptophan and the other 1large neutral1 amino acids.
It has been reported (oldendorf, 1971) that tryptophan, 
tyrosine, phenylalanine, leucine, isoleucine and valine
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compete with one another for transport sites in the 
system, and that this competition is physiologically 
significant for brain tryptophan levels:
Fernstrom and Wurtman (1972) found that rats 
injected with tryptophan showed a rise in plasma tryp­
tophan, brain tryptophan and brain 5-HT. When even 
higher levels of plasma tryptophan were induced by the 
ingestion of dietary protein, however, brain tryptophan 
and 5-HT levels did not change. Correlation analysis 
of their data revealed that brain concentrations of 
both tryptophan and the 5-hydroxyindoles (i.e. 5-HT 
and 5-HIAA) more closely reflected the ratio of total 
plasma tryptophan to its competing amino acids 
(r = 0.95 and 0.89, respectively), as distinct from 
plasma tryptophan levels alone (r = 0.66 and 0.58, 
respectively).
Plasma tryptophan- exists - unique among amino 
acids - in two forms: Approximately 80% reversibly
bound to albumin; and 8 - 20% freely diffusible 
(McMenamy and Oncley, 1958). Various agents 
have been reported to displace L-tryptophan
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from albumin binding sites, including free fatty acids 
(Curzon et al, 1973) and some drugs. McMenamy (1970) 
has reported that, under normal conditions, free fatty 
acids present at molar ratios up to 1:1 with albumin have 
essentially no effect on L-tryptophan association. At 
molar ratios of 2:1 there is a 15% reduction, and at a 
molar ratio of FFA to albumin of 4:1, the tryptophan binding 
site is essentially blocked. Considerable controversy 
exists as to the importance of albumin binding in determining 
tryptophan availability to brain. In humans, for example, 
Perez-Cruet et al (1974) reported a significant positive 
correlation between the ratio of free tryptophan to other 
neutral amino acids, and CSF tryptophan or 5-HIAA levels: 
but not between the ratio of total plasma tryptophan to 
neutral amino acid and CSF values.
Reviewing the "Regulation of 5-hydroxytryptamine 
synthesis", however, Bender observed "if competition between 
available tryptophan and other amino acids influences uptake 
into the brain, then not only will the ability to replenish 
the pool of diffusible tryptophan be important but also the 
size of that pool, since this, and not the total plasma 
tryptophan competes with the other amino acids for the brain 
uptake system. Hence, it is to be expected that factors 
that affect the binding of tryptophan to albumin will/ by 
affecting the size of the plasma diffusable tryptophan 
pool, affect brain tryptophan uptake" (Bender, 1978).
Plasma insulin - and dietary carbohydrate - has been 
reported to influence the partitioning of tryptopban into 
free and bound forms via its effects on plasma FFA activity-
39
In 1971/ Fernstrom and Wurtman (1971b) reported that, in rats, 
insulin injection or ingestion of carbohydrate was associated 
with an increase in total plasma tryptophan, accompanied 
by parallel increases in the concentrations of tryptophan 
and serotonin in the brain. The insulin-induced rise in 
plasma tryptophan seemed paradoxical, as amino acids are 
known to move out of plasma into muscle in the presence 
of insulin. Insulin also acts to free albumin from 
existing fatty acid bonds, however, and may thereby alter 
the affinity of albumin for tryptophan. Thus, while the 
levels of amino acids free in the plasma - including trypto­
phan's 'large neutral' competitors - fall in the presence 
of insulin, the level of bound tryptophan is hypothesized 
to increase. If the bound fraction does play a signific­
ant role in tryptophan blood/brain transport, as has been 
suggested, this would potentiate a unique post-prandial 
advantage for tryptophan molecules in the competition for 
brain uptake.
The total amount of tryptophan in plasma is known 
to' be unusually large in view of its function in body 
protein synthesis (Munro, 1974) although tryptophan is 
least abundant of the essential amino acids. In rats,
Munro reported the ratio of tryptophan to phenylalanine to 
tyrosine in the total amino acid pool of the body, and free 
in the tissues, to be about 1 : 4 : 4; as compared with 
1 : 1.2 : 1.4 in plasma. Taking the non-bound fraction 
of tryptophan only, the ratio becomes 1 : 4.8 : 5.8, as 
in the tissues, implying that the bound tryptophan in
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plasma may represent an excess or reservoir not present 
in the tissues and not present for any of the other amino 
acids. What would be the function of such a unique 
feature of tryptophan metabolism? The following studies 
have sought to further document an insulin-induced, fat- 
mediated advantage for tryptophan availability to brain, 
with specific reference to its free and bound forms.
Knott and Curzon (1972) and Curzon and Knott (1974), 
studying rats, have reported that alterations in plasma 
FFA level - both physiologically and drug induced - correl­
ated positively with plasma free tryptophan levels, brain 
tryptophan levels and those of 5-HT and 5-HIAA. Gessa 
and Tagliamonte (1974) have published similar findings.
No data for other neutral amino acids values were given.
Madras et al. (1973) administered insulin or a 
glucose solution to rats, reporting similar results for 
both treatments: a large increase in total serum trypto­
phan, restricted to its bound fraction: a decrease in 
free tryptophan; a large decrease in plasma FFA levels: 
and a significant rise in brain tryptophan. In a second 
experiment, they fed fasted rats one of two diets: carbo­
hydrate plus fat, or carbohydrate only. Following both 
diets, they found a rise in total tryptophan, bound trypto­
phan and brain tryptophan; and a fall in free tryptophan, 
tyrosine and FFA. Animals fed carbohydrate plus fat 
showed significantly lesser falls in plasma FFA and serum 
free tryptophan, although brain tryptophan levels were not 
dissimilar.
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Lipsett et al. (1972) reported the administration 
of glucose to human subjects caused a decrease in serum 
free tryptophan, without affecting the concentration of 
bound tryptophan, accompanied by a 50% fall in plasma FFA. 
Again, no values for competing amino acid levels were 
included.
The previous studies illustrate the controversy over 
the relative importance of factors regulating tryptophan 
access to brain: and, further, suggest a species difference 
in the effect of insulin on plasma tryptophan. Confirming 
Fernstrom and Wurtman's (1971b) initial findings in rats, 
the Madras et al. group reported an increase in total plasma 
tryptophan following insulin injection in rats, but attrib­
utable to its bound fraction only, and an increase in 
brain 5-HT. However, these results conflict with Knott 
and Curzon's work (1972: 1974) which indicates free plasma
tryptophan values as best reflecting brain levels. In 
humans (Lipsett et al. 1973), total tryptophan was found 
to fall in the presence of insulin, although its bound 
fraction remained unchanged, while the levels of amino 
acids competing with tryptophan for brain uptake were 
reported to fall markedly (Fernstrom and Wurtman, 1973).
In contrast, the Perez-Cruet et al. work (1974) specific­
ally pointed to the free tryptophan/other neutral amino 
acid ratio as being physiologically significant in humans.
It has been suggested, in explanation of some of the 
data discrepancies, that tryptophan metabolism may be 
altered in response to drug stimuli, food deprivation, or 
when increases exceed the normal physiological range.
42
Fernstrom and Wurtman (1974) have hypothesized that the 
increase in total plasma tryptophan under the impact of 
insulin seen in the rat, results from 11. . . still other 
tryptophan molecules migrat(ing) from red blood cells of 
adjacent tissue. . .", thus replenishing the free fraction, 
and raising the total tryptophan level. In humans, this 
secondary migration of free tryptophan does not occur, but 
the shift of free tryptophan " . . .  into the insulin-immune 
reservoir helps to keep the total blood tryptophan level 
in rough equilibrium. . .", as against the reduction of 
the other neutral amino acids.
More recently, Yuwiler et al. (1977) investigated the 
effects of pH, FFA displacement of bound tryptophan, and 
competing neutral amino acid levels on the transfer of 
tryptophan from blood to brain in rats, and its partition­
ing into free and bound forms; an attempt to quantify the 
relative importance of these factors for determining brain 
tryptophan levels. They reported: 1) that a considerable 
fraction of bound tryptophan is stripped from albumin-sites 
during blood/brain transfer; 2) that uptake is dependent 
on blood tryptophan concentration; and 3) that amino acid 
competition for carrier sites is quantitatively the most 
important factor in regulating tryptophan uptake into brain. 
On the basis of their calculations Yuwiler et al. conclude 
"that the 'effective* tryptophan concentration in tryptophan- 
albumin solutions (i.e. that required to account for the 
observed tryptophan uptake into brain) greatly exceeds the 
measured free tryptophan and instead approximates half or 
more of the total tryptophan concentration . . . (and that)
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the combination of albumin binding and amino acid compet­
ition permits large changes in ‘effective® tryptophan 
concentration within a physiological range of total 
tryptophan concentration.1
An index of * effective* tryptophan concentration has 
been reported by Fernstrom et al. (1973) based on three 
separate studies in rats. They reported that diet-induced 
changes in brain tryptophan correlate as well with the ratio 
of plasma tryptophan to tyrosine, leucine, isoleucine or 
valine, as with the ratio of tryptophan to the sum of its 
transport competitors. Their results also suggest that, 
"with the possible exception of phenylalanine, which appears 
to compete less effectively than the others, . . .  no single 
neutral amino acid is a more potent competitor with trypto­
phan for uptake than any other."
The following studies have sought to relate tryptophan 
and sleep, and diet, tryptophan and sleep, in human subjects, 
in the light of certain of the metabolic factors described 
above.
4. Chen et al. (1974) measured free, bound and total 
plasma tryptophan, and polygraphic sleep variables, through­
out the night in six female volunteers. Diet was controlled 
for accepted normal balanced proportions of fat, carbohydrate 
and protein on the day prior to the study. They reported 
no direct temporal relationship between any of the plasma 
tryptophan levels and specific sleep stages. A positive 
correlation was found, however, between mean free trypto­
phan levels and REM sleep; and a negative correlation 
between free tryptophan and non-REM sleep. An inverse
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relationship existed between free and bound tryptophan 
levels. The authors noted a diurnal variation such that 
free tryptophan levels were highest in the first half of 
the night. These results are in theoretical agreement 
with those of the Phillips et al. (1975) study cited 
earlier (page 23 )/ in which a high CHO/low fat diet was 
found to be associated with an increase in REM sleep.
5. Al-Marashi and Freemon (1977) compared sleep under 
different dietary conditions in four female subjects. One 
diet was designed to supply a high amount of natural trypto­
phan (2.031g/2245 calories daily) within 130g protein,
113g fat, 173g CHO. A second, low-tryptophan diet 
(0.518g/1943 calories daily),, consisted of 47g protein,
77g fat and 343g CHO. The subjects consumed the diets 
for five consecutive days according to a balanced cross­
over design. Sleep was recorded for statistical evaluat­
ion during the last two nights of each 5-day period. The 
volunteers were dieticians and not blind to experimental 
treatment. The only statistically significant differences 
found between the two dietary conditions were in number 
of awakenings and time spent awake during the night, which 
were reduced with the high tryptophan diet.
Hartmann et al. (1977) tested the effect of tryptophan 
and leucine supplements (2 grams) with high protein versus 
no protein diets on subjective daytime arousal in twelve 
male and female subjects. They found the high protein 
plus tryptophan condition significantly associated with 
more reported sLeepiness on the Stanford Sleepiness Scale. 
Cancelling out the amino acid supplements, they reported
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the no protein (largely carbohydrate) diet produced* 
significantly more sleepiness than the protein diet 120 
minutes after the meal.
Porter and Horne (1981) studied the effects of ingest­
ing different carbohydrate loads on EEG sleep in six male 
young adults. The CHO loads were given in the form of 
bedtime snacks of common foodstuffs, to provide either 
130g, 47g or Og carbohydrate. Subjects were exposed for 
3 nights to each of the three conditions, according to a 
balanced design. The high carbohydrate condition was 
found to be associated with significantly reduced stages 
0 + 1  and 4 sleep, and significantly increased REM sleep. 
The authors concluded that "relatively high blood glucose 
levels are required to alter sleep, and perhaps lead to 
more Restful* sleep."
6. Summary and Conclusions
In summarizing this section, I shall draw on all of 
the data presented when suggesting general conclusions, 
but confine my observations of specific sleep parameters 
to human studies only prior to setting out the hypothesis 
of the present study in detail.
The data appear to support a role for 5-HT in the 
neurobiochemistry of sleep, as evidenced by (i) the 
insomnia and disruption of sleep associated with techniques 
which decrease 5-HT levels: and (ii) the various forms of 
sedative effect associated with attempts to increase 5-HT, 
in particular the reversal with 5-HTP of insomnia in cats 
(Pujol et al. 1971), and REM disruption in cats (Delorme
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et al. 1965) and humans (Wyatt et al. 1969; Wyatt et al.
1970a) associated with PCPA.
The nature of this role is difficult to infer, however, 
in view of the varied, inconsistent, and sometimes dose- 
related effects on sleep parameters reported with precursors 
5-HTP and tryptophan:
Of the 9 investigations cited of 5-HTP in humans,
(i) 6_ reported increased REM sleep (Wyatt et al.
1969; Wyatt et al. 1971a; Mandell et al. 1964;
Zarcone et al. 1973; Wyatt et al. 1970b;
Wyatt et al. 1970c).
(ii) 1 reported reduced REM latency (Oswald et al. 1966)v.
(Ill) reported increased REM density or efficiency 
(Wyatt et al. 1970c; Zarcone et al. 1973);
(iv) 1 reported a reduction in stage changes 
(Zarcone et al. 1973).
Of the 14 investigations of L-Tryptophan in humans,
(i) 4 reported subjective drowsiness (Griffiths
et al. 1972; Greenwood et al. 1974;.Oswald et al. 1966).
(ii) _6 reported reduced sleep latency (Williams et 
al. 1969; Hartmann, 1970; Hartmann et al. 1971;
Hartmann et al. 1974; Hartmann and Elion, 1977;
Griffiths et al. 1972);
(iii) 3 reported increased TST (Wyatt et al. 1970d;
Hartmann et al. 1971; Mendels and Chernik, 1972);
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(iv) 5_ reported increased NREM and SWS (Wyatt et 
al. 1970d; Williams et al. 1969; Hartmann et
al. 1974; Griffiths et al. 1972; Nicholson & Stone, 1979)
(v) 3 reported reduced REM latency (Oswald, 1966;
Williams et al. 1969; Griffiths et al. 1972);
(vi) _2 reported decreased Stage REM (Wyatt et al,
1970d; Hartmann et al. 1974, and 3 increased 
Stage REM (Wyatt et al. 1970d; Griffiths et 
al. 1972; Nicholson & Stone, 1979)
(vii) 1 reported reduced REM density (Williams et 
al. 1969);
(iix) 1 reported reduced motility (Williams et al.
1969) and 4 reduced wakefulness in the night 
(Williams et al. 1969; Hartmann, 1970; Mendels 
and Chernik, 1972; Griffiths et al. 1972).
Viewing these data as a whole, the consistent reported 
association between 5-HTP and augmented REM (latency, amount, 
density), contrasts with the more generalized positive 
correlations found between tryptophan and sleep parameters.
This suggests, in my view, that tryptophan may have effects 
on sleep apart from its role as serotonin precursor. Wyatt 
et al. (1970) previously made a similar observation.
Whatever the role of 5-HT and its precursors in the 
architecture of sleep, experimental evidence suggests it 
may be mediated by ingestion of carbohydrate, providing 
a potential biochemical correlate for an association between
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satiety and lowered arousal. The Phillips et al. (1975), 
Al-Marashi and Freemon (1977), Hartmann et al. (1977) and 
Porter and Horne (1981) findings appear to endorse such an 
hypothesis.
The reported positive correlation between mean free 
plasma tryptophan levels and REM sleep (Chen et al. 1974) 
provides support for the significance of the free trypto­
phan fraction, as opposed to bound or total levels, in the 
biochemistry of sleep. This is incompatible with the 
Fernstrom and Wurtman theory which maintains that albumin 
binding, and the fat content of food, has little signific­
ance for the dynamics of brain tryptophan uptake "probably 
because the affinity of brain for tryptophan is much greater 
than that of albumin" (Wurtman, 1975). I am not qualified 
to comment further on the debate concerning mechanisms of 
carbohydrate and protein metabolism, however additional 
data will be cited in the Discussion, Chapter 5.
C. Work correlating serotonin and feeding.
Finally, recent work in the neural regulation of food 
intake further implies the significance of serotonergic 
systems as a biochemical link between eating and sleeping.
In addition to its suggested role in the induction and 
maintenance of sleep stages (pp 23-4), a review of evidence 
(Blundell, 1977) indicates that experimentally induced 
changes in 5-HT systems are associated with pronounced 
alterations in feeding behavior. In general, manipulations 
designed to increase 5-HT concentration at the synaptic 
cleft or directly activate 5-HT receptors, reduce food 
consumption. Procedures designed to decrease 5-HT
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transmission increase food intake. Blundell concludes, 
" . . .  available data favour the idea that serotonin 
systems play an inhibitory role in feeding, possibly in 
the mediation of satiety."
Evidence compatible with these findings has also been 
reported for precursors tryptophan and 5-hydroxytryptophan 
(Blundell and Latham, 1979; Fernstrom and Wurtman, 1972).
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CHAPTER TWO 
HYPOTHESIS
51
It is commonly reported in the general population 
that a large meal is often followed by a feeling of 
sleepiness or lowered arousal, sometimes accompanied by 
a period of sleep. This behavioural pattern has been 
observed throughout the animal world and in some human 
societies has become culturally established, as in the 
Mediterranean 1 siesta1. It was my purpose to design 
a study in which this- prevalent experience could be 
used to test a theory relating the metabolism of food­
stuffs to the biochemistry of sleep.• Previous studies 
(Chen et al, 1974; Phillips et al, 1975; Al-Marashi 
and Freemon, 1977; Porter and Horne, 1981) have sought
to test the effect on EEG sleep of manipulating fat,
\
carbohydrate and protein intake throughout one or more 
previous days. By contrast, the present study was 
designed to explore the short-term impact on plasma 
amino acids and sleep patterns of a single large increase 
in a particular constituent, within the context of free 
dietary choice consistent with normal experience.
It was hypothesized that a carbohydrate supplement, 
taken with the evening meal, would be associated with an 
increase in the ratio of total plasma tryptophan to 
tyrosine and phenylalanine, when compared with protein, 
fat, or no supplements in human subjects.
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It was further hypothesized that this ratio at the 
biochemical level would be associated in these subjects 
with altered arousal, as measured by the following 
polygraphic sleep characteristics:
1) decreased sleep latency
2) increased Total Sleep Time
3) decreased REM latency
4) increased REM sleep
5) reduced restlessness in the night
6) increased Slow Wave Sleep
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CHAPTER THREE
METHOD
54
A. GENERAL
The experiment was conducted at the Sleep Laboratory, 
Atkinson Morley's Hospital, London. Twelve healthy male 
subjects, aged 18-25, were recruited from local university 
populations.
Each subject was informed of the requirements of 
the study, and payment was agreed in exchange for reliable 
participation. Subjects undertook not to drink alcohol 
both during and for 12 hours prior to each experimental 
occasion. This control was included as alcohol has been
reported to be associated with a suppression of Stage REM
)
(e.g. Yules et al. 1966).
Subjects also agreed not to engage in unusually 
strenuous physical exercise for the same time period, as 
this has been reported to correlate with increased SWS 
(Shapiro et al. 1975).
Subjects agreed to sleep only in the laboratory during 
the experiment, and to refrain from napping.
All of the subjects were non-smokers.
On recruitment, each subject completed three Beecham's 
Dietary Surveys on successive weekdays (sample, page 55).
The resulting information was analysed for average individual 
total energy intake (Real) and average carbohydrate, fat 
and protein intake (grams), per day.
Each subject subsequently spent two series of 5 nights 
in the sleep laboratory. The first two nights of each
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series were for adaptation purposes when the subjects 
were fitted with sleep recording electrodes and arm 
bandages to allow them to become accustomed to the laboratory 
environment and procedures. Four of the twelve subjects 
who were experienced in the laboratory techniques were 
adapted for one night.
B. EXPERIMENTAL VARIABLE
On the six experimental nights either no supplement 
or a fat, carbohydrate or protein supplement drink was 
given with the evening meal according to the pre-set 
design shown in Table 3.1. The design provides that in 
each session, on the first two experimental nights, each 
of six possible pairs of supplements in both possible 
orders occurred. On the third night of each session, 
the first night's supplement was repeated. The objectives 
in ordering the supplements in this way were:
1. To allow for variability between subjects, 
as by the end of the second session each 
subject had experienced every supplement:
2. To allow for an assessment of any carry-over 
effect from one diet/night to another by a 
comparison of nights 1 and 3, or, if none 
■vere found to exist, an estimate of nightly 
variation of the various parameters:
3. To allow for balanced treatment order as 
by the end of each session, all possible 
treatment combinations in all possible 
orders had been administered.
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TABLE 3.1 Sequence of supplement drinks taken with the 
evening meal by each of twelve subjects, 
during two sessions of three experimental 
nights
SUBJECT SESSION 1 SESSION 2
1 P N P C F c
2 F C F N P N
3 P C P N F N
4 F P F C N C
5 N c N P F P
6 C p C F N F
7 P F P N C N
8 N P N F C F
9 C F C P N P
10 N F N P C  ^P
11 C N C F P F
12 F N F C P C
N = No supplement
F = Fat supplement (equivalent 100% usual daily intake)
C = Carbohydrate supplement (100% usual daily intake)
P = Protein supplement (50% usual daily intake)
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The three types of drink used to provide the 
experimental supplements (Table 3.2) were selected and 
prepared to be as palatable as possible. They consisted 
of:
1. Nefranutrin (Geistlich & Sons Ltd), an orange
flavoured powder of essential amino acids
mixed with water;
2. Prosperol (Duncan Flockhart) an emulsion of 
ground nut and peanut oils in water, whipped 
and flavoured with instant coffee powder or 
drinking chocolate;
2. Hycal (Beecham Products), a fruit-flavoured 
gluco s e drink.
The amount of diet supplement given was made up to
equal 100% of each subject's usual daily intake of carbo­
hydrate and fat, or 50% in the case of protein, as 
assessed previously. It was attempted in this way to 
provide a comparable experimental variable for each subject.
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TABLE 3.2 
Nefranutrin
orange flavoured powder of essential amino acids 
to be made into a drink
Active ingredients: per 13.6g sachet
Essential amino acids -
L-Isoleucine 0.45g L-Leucine 0.72g
L-Lysine HCl 0.97g DL-Methionine 0.71g
L-Phenylalanine 0.39g L-Threonine 0.33g
L-Trytophan 0.16g L-Valine 0.52g
Electrolytes
Sodium 0.9mEq Potassium 0.05mEq
Total nitrogen = 0.5g
Prosperol
50% emulsion of arachis oil (groundnut oil, peanut oil) 
in water, containing the following fatty acids: 
saturated
palmitic 8.3%
stearic 3.1
arachidic 2.4
behenic 3.1
lignoceric 1.1
unsaturated
oleic 56.0
linoleic 26.0
100.0
providing 4.5 cal/ml
Hycal
63% demineralized glucose syrup in water + citric acid 
preservative, colour, flavouring
average ingredients (CHO) per 6 oz bottle:
Glucose (dextrose), 20.57g
Maltose 15.11g
Trisaccharides 12.54g
Tetrasaccharides 10.56g
Pentassacharides 8.88g
Hexa- and higher saccharides 38.58q
TOTAL CARBOHYDRATE 106.24g
Energy value (Kcal) 414
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Sample supplement quantities are given in Table 3.3.
The subjects consumed all of every supplement drink 
given.
Subjects were instructed to eat as they would 
normally during the study, apart from having nothing to 
eat between 14.00 hours and the evening meal served in 
the laboratory. Tea and coffee were allowed in this 
interval.
The subject's usual patterns of tea and coffee intake 
were allowed because (1) I was testing for an effect of 
diet superimposed on normal eating habits which include 
the drinking of tea and coffee: and (2) the effects of 
withdrawing caffeine could not have been controlled for 
or estimated within the terms of the experiment.
C. DATA COLLECTION AND ANALYSIS
1. Diet Beecham's Dietary Surveys were completed 
by the subjects on all study days. Reported food intake 
was analysed for total Kcal and grams carbohydrate, fat 
and protein by students of the Department of Nutrition 
and Biochemistry, University of Surrey, Guildford.
2. Plasma amino acids Eight millilitres of blood 
was withdrawn 30 minutes after cannula insertion and hourly 
thereafter, continuing where feasible throughout sleep. A 
remote blood collection system was used whereby a flexible 
indwelling cannula is connected by means of sterile fine- 
bore tubing to a constant normal saline dripfeed in the 
laboratory adjacent to the bedrooms. The technique is a
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modified version of the one published by Van Kirk and Sassin 
(1969) and allows blood to be sampled regularly without 
disturbing the sleeping subject.
With the subject in bed the system is set up in the 
following way: An 18g flexible cannula is sited in a prom­
ising forearm vein avoiding where possible the wrist and 
elbow joints. This is important as the need to immobilize 
the joint with an armboard can be extremely disturbing to 
the sleeper and may result in muscle pain after a while, or 
even cramp. It is also desirable not to choose a very 
superficial vein as they tend to be more vulnerable to changes 
in temperature or position and go into spasm. They are also 
often not of sufficient size to allow relatively longterm 
sampling and 'tire' easily.
Once the cannula is in position, a catheter kit flushed 
through with saline is connected to the cannula. These 
kits are prepared in advance and consist of approximately 
9 feet of fine-bore plastic tubing threaded through an equal 
length of slightly larger diameter tubing. This collar 
tubing is an adaptation which we have made in our laboratory 
and provides insulation so that the saline passing through 
the inner tubing does not cool down and possibly disturb 
the subject. The outer jacket of tubing also reduces the 
possibility of a kink forming in the tube as the subject 
moves in his sleep. The diameter of the inner tubing is 
1mm: that of the outer insulating tubing, approximately 4mm.
At one end of the tubing a Luer connector is fitted, and at 
the other, a Touhy adaptor. The whole kit is then coiled, 
wrapped and sterilized by gamma irradiation.
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The Touhy adaptor is fitted firmly into the cannula.
The tubing, with a 10ml syringe on the other end to keep 
the system flushed clear with saline, is then carefully 
taped along the length of the arm so as not to feel extra­
neous to the subject. The syringe end of the catheter 
kit is then passed through a hole in the wall behind the 
subject's head and connected to the saline drip in the 
laboratory next door via two 3-way stopcocks.
Once the system is established and the saline running 
“freely, the subject's forearm is gently but firmly wrapped 
with crepe bandage. The drip rate is then adjusted to 
approximately 12 drips per minute.
The saline infusion has previously been warmed to 
body temperature. Normally sodium heparin is added 
(5,OOOi.u./500ml saline) to reduce the potential of a clot 
forming anywhere in the catheter kit system during sampling. 
This is particularly likely to occur with prolonged frequent 
sampling, if relatively large volumes are being drawn, or 
when the draw is slow due to position effect of the subject's 
body or a tired vein. Heparin was not used in this study, 
however, as it has been reported to effect free tryptophan/ 
albumin binding (Curzon and Knott, 1973). The volume of 
the samples drawn, 8 ml, was relatively small and the entire 
sampling procedure could usually be accomplished within 
about 60 seconds in these healthy young male subjects.
Under these conditions, I consider that my previous experience 
in sleep studies using remote blood collection was an important 
factor in the sampling success rate of 84%. Nevertheless
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not using heparin does decrease the margin of error within 
which the technique functions optimally and in my view 
contributed to the number of occasions when sampling was 
unsuccessful (see Missing Data, page 66).
Once the system is established and the subject asleep 
the procedure for sampling is as follows: A sterile 10ml
syringe is first used to draw off the saline held in the 
catheter kit tubing from one of the 3-way stopcocks connected 
to the dripfeed. The fine-bore tubing contains a volume 
of 2.5-3 mis. Four millilitres are drawn to ensure whole 
blood is entering the syringe. Using a fresh syringe, 
the sample is then drawn and put into a heparinized plastic 
blood collection tube which is. stoppered and placed in a 
container of iced water. The catheter system is then 
flushed through with approximately 5 mis of normal saline, 
using a supply from a 50 ml. syringe which is kept attached 
to the stopcocks. The drip is then resumed and the sample 
spun in a refrigerated centrifuge. The plasma is pipetted 
into prelabelled storage tubes according to assay and frozen, 
usually within 30 minutes of sampling.
When everything functions optimally - subject, equipment, 
and experimenter! - this technique allows blood chemistry 
to be monitored within a sleeping subject who is unaware of 
the sampling. This is inevitably not always the case, 
however, for any or all of the reasons previously mentioned.
I was concerned in this study that my polygraphic sleep data 
should be as 'normal * as possible. I took every care that 
I knew before "lights out" to ensure the sampling would be 
trouble-free both for my subjects and myself. If sampling
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proved difficult, given I was satisfied the subject was not 
in any way at risk, I elected not to pursue the blood sample 
rather than chance disrupting the sleep data by possibly 
waking the subject. It was a difficult balance to reach 
and was a matter for my judgement based on experience. As 
reported recently in Sleep (Adam, 1982) sleep patterns in 
subjects undergoing blood sampling are in any case signif­
icantly different from those recorded in the same subjects 
without sampling.
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TABLE 3.3
Sample supplement quantities
*
Nefranutrin 7 sachets 30g protein
in 500ml water
Prosperol 180ml 90g fat
Hycal 12 fl oz 223g carbohydrate
* approximate amino acid doses provided by Nefranutrin 
supplement (based on an average of 7 packets per 
supplement drink)
L-Isoleucine 3.15g
L-Lysine 6.79g
L-Phenylalanine 2.73g
L-Tryptophan 1.12g
L-Leucine 5.04g
DL-Methionine 4.97g
L-Threonine 2.31g
L-Valine 3.64g
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Addenda to TABLE 3.3
A) RANGE OF AMOUNT OF SUPPLEMENTS GIVEN TO SUBJECTS
1. Carbohydrate - 100% of each subject’s mean daily intake 
Hycal, total carbohydrate = 1 8  grams/ounce
range (12 subjects) corresponding
supplement quantities
19Og - 386g 312ml - 625ml
2. Fat - 100% of each subject's mean daily intake 
Prosperol, total fat = 0.5 grams/millilitre
range (12 subjects) corresponding
supplement quantities
70g - 166g 140ml - 322ml
3. Protein - 50% of each subject's mean daily intake
Nefranutrin, essential amino acids = 13.6 grams/sachet
range (12 subjects) corresponding
supplement quantities
26(53)g - 80(161)g 2 - 7  sachets
L-Tryptophan dose per supplement 
@ 0.16g/sachet = . .32g - 1.12g
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Samples were analysed for total tryptophan, tyrosine 
and phenylalanine in the laboratory of Doctor M K Gaitonde,
St. George's Hospital Medical School, London, by research 
assistant, Miss G Jones, assisted by the experimenter. |
Plasma tryptophan was assayed by the modified Denckla 
and Dewey method (Denckla and Dewey, 1956) described in 
Gaitonde et al. (1979), based on the formation of norharman.
Plasma tyrosine was assayed by semiautomated fluoro- 
metric analysis as reported in Evans et al. (1979).
Plasma phanylalanine was measured using a modification 
of the fluorometric procedure described by Blau et al. (1977).
3. Sleep. The subject's sleep was recorded poly- 
graphically on all study nights to arrive at a continuous 
measure of EOG, EEG and EMG activity in the usual manner 
(Rechtschaffen and Kales, 1968). Electrode references, 
based on the International Ten-Twenty System of Electrode 
Placement, included: (i) two bipolar electro-oculograms 
referred from the upper outer canthus of one eye to the 
lower outer canthus of the other eye, and vice versa:
(ii) one electroencephalogram using either a C^-A^ or a 
C^-A^ reference, with the other as spare;.and (iii) one 
electromyogram using the SM^ - SM£ bipolar reference.
High frequency filters were used on all channels except 
the EMG. Paper speed was 15mm/sec; and calibration,
50mv/cm.
Recording time was kept as closely as possible to 
the individual requirements of each subject, with the proviso
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that each be regular within his own norm. Sleep records 
were labelled with a code to allow for subsequent blind 
scoring.
A subjective assessment of sleep quality was determined 
by means of an analogue scale administered each study 
morning (Figure 3.1).
Of 72 possible recordings/ 71 sleep/nights had been 
successfully recorded at the end of data collection. These 
records were scored blind by the experimenter in 20 second 
intervals according to internationally agreed criteria 
(Rechtschaffen and Kales/ 1968).
Briefly/ the criteria applied to define the sleep 
polygraphs were as follows:
Stage 0 - wakefulness - possible Rapid Eye Movements 
(REMs) and eye blinks in the EOG; a low voltage, mixed 
frequency EEG which may be characterised by alpha activity 
(9 - 12 cps); relatively high tonic EMG;
Stage 1 - transition from wakefulness to sleep - slow, 
or "rolling" eye movements (SEMs); decrease in the amount, 
amplitude and frequency of alpha activity (to less than 50% 
of the epoch); stable or decreasing EMG activity;
Stage 2 - 1 light sleep* - presence of sleep spindles 
(12 - 14 cps) and K complexes, and absence of sufficient slow 
waves to define Stages 3 and 4;
Stage 3 - transition from light sleep to deep sleep - 
record in which at least 20% but not more than 50% of an 
epoch presents delta waves of 2 cps or slower with amplitudes
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Figure 3.1
Overall Sleep Quality
Very good Extremely bad
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greater than 75 microvolts:
Stage 4 - ‘deep’ sleep - record in which more than 50% 
of an epoch consists of delta activity as defined above;
Stage REM - often associated with reported dreaming - 
defined by the concomitant appearance of episodic REMs and 
a low voltage, mixed frequency EEG, with EMG activity 
characteristically at its - lowest;
Movement Time (MT) - epochs in which more than half 
the EEG and EOG traces are obscured by muscle tension, 
amplifier blocking, or artifact associated with movement of 
the subject;
Total Sleep Time (TST) - amount of time within the 
interval from first sleep spindle to final awakening, 
scored as Stages 1, 2, 3# 4, and 5;
Sleep Latency -■ the time interval from ' lights
out1, to first clear sleep spindle of at least 0.5 seconds 
duration;
REM Latency - interval from first sleep spindle to 
start of first REM period;
Slow Wave Sleep (SWS) - Stages 3 + 4 ;
NonREM Sleep (NREM) - Stages 1, 2, 3, and 4 collectively.
% Sleep Stage - Sleep Stage in minutes/TST in minutes
Sleep Efficiency - TST in minutes/TRT in minutes
The resulting scores for each sleep night were punched 
on computer cards and analysed by a program designed to 
calculate the above data.
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4. Weight Subjects were weighed each study morning 
on arising, and the weights charted in kilograms.
D. EXPERIMENTAL PROTOCOL
Thus, on each experimental night (Table 3.4), a 
subject arrived at the laboratory at approximately 19.15h. 
He handed in the day's dietary survey, ordered his evening 
meal from a hospital canteen menu, and received an 18g 
cannula in a forearm, alternating arms each night.
Thirty minutes after the dripfeed was established, 
during which the subject sat quietly, a resting blood 
sample was taken. Dinner plus supplement was served 
immediately thereafter, i.e. 20.00 - 20.30h.
At approximately 22.00h electrodes were applied for 
polygraphic sleep recording. When the subject indicated 
he wished to go to bed the remote blood collection system 
was established, bedroom lighting was turned off, and 
the polygraphic recording begun.
When the subject indicated he was ready to get up in 
the morning, blood collection and sleep recording apparatus 
was removed, sleep quality scales were administered, and 
the subject was weighed.
E. STATISTICS
Statistical analysis of the data was performed by 
B. R. Kirkwood, Computer Centre, Chelsea College, London, 
and A. Bhat, St. George's Hospital Medical School, London, 
in collaboration with the experimenter.
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TABLE 3.4
Experimental night schedule
19.15 subject arrives, hands in day*s dietary survey,
orders evening meal, prepares for bed
19.40 cannula inserted, drip set up in bedroom
20.15 resting sample drawn
20.20 dinner served + appropriate supplement,
dietary survey completed
21.30 sample 1, subject moved to laboratory for 
wiring-up procedure
22.30 sample 2, subject returns to bedroom, leads 
tested, drip set-up finally for the night,
*Lights Out1, record started
(sampling continues hourly + continuous 
polygraph record)
time at which subject 
wakes spontaneously, eg
07.40 stop sampling, stop recording, remove cannula 
and electrodes, administer sleep quality 
analogue scale, weigh subject
Missing Data
At the outset of the study I planned to collect 13 
blood samples from each of 12 subjects on each of 6 experi­
mental nights, or a total of 936 possible samples. This 
calculation was based on a schedule whereby a resting sample 
would be drawn at approximately 20.15, followed by one 
sample every hour until 09.15 or whenever the subject awoke.
As the study required that each subject awoke spontaneously, 
the potential number of samples to be drawn in fact varied 
from subject to subject.
At the end of the study, blood had been sampled 
successfully 715 times out of a total of 854 possible occasions 
Samples were missed for several reasons:
1. On 5 occasions, I took the decision to miss a 
scheduled sample in order to keep the polygraphic data 
collection running smoothly.
2. On 1 of the 72 subject/nights, no blood was 
collected when it proved impossible after three attempts
to successfully insert a cannula (Subject 3, Session - night 3)
3. On the second experimental night of the first 
session, Subject 10 experienced pain in his arm. Sleep and 
amino acid data for this night have been excluded from the 
study results and analysis.
4. The remaining 110 samples were missed when the 
remote blood collection system described earlier did not 
function optimally either because of venospasm or the 
occlusion of the connecting tube due to the sleeping 
position of the subject. In most cases this meant that
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only one or two samples were missed in a night (see Addendum 
III, Sleep Histograms and Amino Acid Values) as the draw was 
resumed when the subject changed position. However, Subject 
3 was excluded from the analysis of blood sample results as 
sampling was only possible on 33 of a possible 72 occasions 
(45%). In the remaining 11 subjects sampling was successful 
an average of 86% of attempts (rangeing from 70 to 99%).
On technical grounds the sleep record obtained for 
Subject 10 for the last night of the second experimental 
session was discarded.
Where necessary in the analysis missing values have 
been estimated using the rest of the data.
F. FREEZER BREAKDOWN STUDY
Two-thirds through data collection, the freezer in which 
the plasma samples were stored was inadvertently turned off, 
and remained off for approximately 72 hours. To assess 
any damage to the stored plasma, the following re-enactment 
of the accident was undertaken: All plasma samples were re­
moved from the original freezer for storage at -20°C elsewhere. 
A similar quantity (^2,000 10ml tubes) of dummy samples - made 
up of distilled water - was frozen in place of the original 
plasma, to approximate as closely as possible the original 
conditions in the freezer. 3ml extra plasma, in addition to 
the usual 8ml sample, was subsequently collected on a total of 
16 occasions from three subjects. Sixteen paired sets 
of plasma were prepared from these samples. One set was 
immediately deep frozen, and remained at -20° Centigrade.
The second set was placed in the original freezer with the 
frozen distilled water samples. The freezer was fitted 
with an internal thermometer. Once the new samples
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were frozen, the electricity supply was turned off and 
allowed to remain off with the lid closed for 72 hours 
thus' exposing one set of the paired samples as nearly as 
possible to the conditions thought to have occurred in 
the accident.
At the end of 72 hours the freezer was opened, the 
internal temperature was noted to be 13°C in the centre 
of the cabinet, although there was still some light 
frost on the sides as before. The samples were then 
re-frozen.
The 16 paired samples were analysed for total trypto­
phan by an appropriately experienced technician, blind 
to the conditions of the experiment.
Comparing the paired values, the range of variation 
was found to be within normal test/re-test limits. On the 
basis of these results it was concluded that the amino 
acid data of the experiment had not been compromised and 
the study was completed.
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TABLE 3.4
COMPARATIVE ANALYSIS OF PAIRED PLASMA SAMPLES 
Tryptophan
Subject Sample 
- 20°C
nmol/ml Sample
13°C
nmol/ml %
M.S. R-x 61.8 R-x1 68.7 111
1—X 53.1 1-x1 51.4 97
3-x 41.0 3-x1 42.8 104
S.M. R-x 82.5 R-x1 79.9 97
2.x 61.8 2-x1 61.8 100
4-x 84.2 4-x1 63.5 75
5-x 65.2 5-x1 65.2 100
7-x 69.5 7-x1 65.2 94
9-x 54.0 9-x1 53.1 98
11—X 52.7 11-x1 47.9 91
V.F. R-x 54.0 R-x1 50.5 94
2-x 45.3 2-x1 44.5 98
4-x 39.3 4-x1 38.4 98
6-x 45.3 6-x1 47.9 106
8-x 49.7 8-x1 47.1 95
10-x 45.8 10-x1 45.3 ' 99
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CHAPTER FOUR 
RESULTS
l
/
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A. SUMMARY OF RESULTS
Evidence is presented in support of the hypothesis 
that, in human subjects, a carbohydrate supplement taken 
with the evening meal is associated with an increase in 
the ratio plasma tryptophan/other neutral amino acids in 
the subsequent 8 hours.
Evidence is presented in contradiction to the hypo­
thesis that an increase in the ratio plasma tryptophan/ 
other neutral amino acids is related significantly to any 
of the EEG and subjective sleep characteristics examined.
Sleep cycle length was found to be significantly related 
to individual subject, irrespective of diet treatment.
The subject's dietary intake was found to vary from 
the assessments made prior to the experiment, sometimes 
markedly.
Subjects retired to bed significantly earlier following 
the carbohydrate supplement as opposed to protein, fat or 
no supplement. The interpretation of this finding is unclear.
B. 'CARRY-OVER* EFFECT
To determine the presence or absence of a consistent 
effect of one diet/sleep condition on the subsequent nights1 
measurements, an analysis for carry-over effect was under­
taken. Where each supplement occurred on the second 
experimental night in the study design (p 57) the values 
for a particular sleep characteristic - e.g. REM - for the 
first and third nights of that session were compared by 
means of a paired T-test. All sleep characteristics were 
examined in this way.
These analyses showed no evidence of a consistent 
carry-over effect for any of the diet supplement conditions. 
Data from the third night of each experimental session was
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therefore used to provide an estimate of nightly variation 
of the various parameters.
C. DIET SUPPLEMENT CONDITION AND PLASMA AMINO ACIDS
1. Tryptophan, tyrosine and phenylalanine
The relationship between diet supplement and 
plasma levels of tryptophan, tyrosine and phenylalanine 
were examined. An analysis of variance with diet and 
subject as factors was carried out for each of the amino 
acids measured using the results from the first two nights 
of each session (Table 4.1).*. The average values over the 
first eight hours"were used.
These analyses showed:
a) all of the amino acid values varied signi­
ficantly from diet to diet;
b) All of the values varied significantly 
(p <  0.001) from subject to subject;
c) There was a significant (p<0.05) interaction 
between diet and subject for the average level of trypto­
phan over the first 8 hours.
2. Log (tryptophan/tyrosine)
The relationship between diet supplement and 
the ratio of tryptophan to tyrosine in the plasma was 
examined. The average values over the first 8 hours 
for each of the diets were used, based on the first two 
nights from each session. Logarithms of the ratios 
were taken to normalize the data and stabilise the 
variances. These results were presented in Table 4.2. 
Also shown are the ratios corresponding to the logarithmic 
values.
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These analysis showed that:
a) the average nightly log (tryptophan/tyrosine) 
varied significantly (p <0.01) from diet to diet. The 
ratio for the fat supplement diet (0.82) was almost the 
same as that for the no supplement condition (0.80). 
However, the ratio for the protein diet (0.88) was 8% 
higher; and that for the carbohydrate supplement (0.96) 
was 16% higher than the fat or no supplement conditions, 
and 8% higher than the protein supplement condition.
b) the average nightly log(tryptophan/tyrosine) 
varied significantly (p<0.05) from subject to subject.
c) there was no significant interaction between 
diet and subject
3. Log(tryptophan/tyrosine + phenylalanine)
A similar analysis to that for log(tryptophan/ 
tyrosine) was carried out. Logarithmic values and corres­
ponding ratios for each diet condition are presented in 
Table 4.3
These analyses showed that:
a) the average nightly log(tryptophan/tyrosine + 
phenylalanine) varied significantly (p<0.05) from diet 
to diet. The ratio for the fat supplement (0.38) was 
almost the same as that for the no supplement condition 
(0.40). However, there was a linear increase from the 
fat or no supplement conditions to the carbohydrate 
supplement to the protein supplement such that the ratio 
associated with the carbohydrate supplement (0.45) was 
14% higher, and that for the protein supplement (0.49) 
was 20% higher.
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b) the average nightly log (tryptophan/tyrosine + 
phenylalanine) varied significantly from subject to 
subject.
c) there was no significant interaction between 
diet and subject.
D. PLASMA AMINO ACID LEVELS AM3 SLEEP CHARACTERISTICS
The relationship between each of the following sleep 
characteristics and each of the following amino acid 
measurements was examined.
Sleep characteristics: 
sleep latency 
REM latency 
%REM 
%SWS
movement time 
Amino acid measurements: 
tryptophan 
tyrosine 
phenylalanine 
log (tryptophan/tyrosine) 
log (tryptophan/tyrosine+phenylalanine)
Both the average values over the first 8 hours and 
the maximum values during the night were used in all cases 
for sleep latency and REM latency, where average values 
for the first 3 hours were used.
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In practice the hypothesized relationship between the 
amino acid ratios and increased Total Sleep Time could not 
be examined as it was not possible to control conditions 
so that the subjects awoke spontaneously on all occasions. 
This point is discussed further in Chapter 5.
These analyses showed that none of the sleep charact­
eristics varied significantly with any of the amino acid 
measurements (Figures 1 -40).
Subject 8 was found to be a "short sleeper" with an 
average Total Sleep Time over the six experimental nights 
of 337.5 minutes. The average for the remaining 11 subjects 
was 464 minutes (7 hours 44 minutes). A re-run of all 
analyses was made excluding the data from Subject 8. No 
significant correlations between sleep characteristics and 
amino acid measurements were found in this analysis.
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E. SLEEP CYCLE LENGTH
1. Sleep cycle length was examined in relation to
diet supplement condition. The mean sleep cycle length 
for each subject for each experimental night was calculated, 
based on the duration in minutes of the first three intact 
NREM-REM cycles (Table 4.4). An intact cycle was defined 
as a period of NREM plus the subsequent period of REM 
sleep, in which less than one minute of wakefulness had 
been scored.
An analysis of variance was carried out, with diet 
and subject as factors, based on the first two nights from 
each session. These analyses showed that:
a) mean sleep cycle length did not vary significantly 
with diet:
b) but did vary significantly with subject (p = <0.05);
c) there was no interaction between diet and subject.
2. As mean sleep cycle length was found to be related to 
subject, I wondered if this apparent correlation could be
understood in terms of body weight. Previous works suggests
body weight to be significantly related to sleep variables 
(Crisp, 1967; Lacey, 1975; Crisp et al. 1973; Adam, 1977b; 
Danguir & Nicolaidis, 1979), including sleep cycle length 
(Adam, 1977c).
The relationship between sleep cycle length and body 
weight the following morning was examined in these subjects, 
using the mean sleep cycle lengths for each experimental 
night as calculated previously. Morning body weights were
123
TABLE 4.4. Mean intact sleep cycle length in minutes 
for each of the diets, based on the first 
two nights from each session.
Sleep Cycle Length (mins)
Diet/ No Supple- Fat Carbo- Protein Total Mean
Subject ment hydrate
1. 86.4 87.0 75.8 93.7 342.8 85.7
2. 143.5 141.9 86.7 101.3 473.3 118.3
3. 97.1 124.1 92.8 93.3 407.4 101.8
4. 94.7 110.9 99.0 97.4 402.0 100.5
5. 95.1 89.6 87.4 91.0 363.0 90.8
6. 70.4 76.4 77.8 90.0 314.6 78.6
7. 99.2 98.4 101.9 92.0 391.5 97.8
8. 88.8 84.5 113.3 91.0 377.7 94.4
9. 75.8 100.6 76.7 103.3 356.3 89.1
10. 87.6 103.4 102.0 100.0 392.9 98.2
11. 74.4 99.1 88.9 97.9 360.3 90.1
12. 109.1 101.9 90.2 113.2 414.5 103.6
Total 1122.0 1217.8 1092.4 1164.2 4596.4
Mean 93.5 101.5 91.0 97.0 95.8
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found to fluctuate within individual subjects. An index
2of body mass, weight/height x 100, was calculated for 
each subject on each occasion (Table 4.5). Mean sleep 
cycle length was compared with body mass index by means 
of Pearson's correlation co-efficient. These analyses 
yielded a correlation co-efficient of r = .16, which did 
not reach significance levels (Figure 4.41).
3. Mean sleep cycle length was examined in relation to 
plasma amino acid values by means of Pearson's correlation 
co-efficients. Both average values over the first eight 
hours, and maximum values for the night were used for the 
following data: tryptophan; tyrosine; phenylalanine;
log (tryptophan/tyrosine; log (tryptophan/tyrosine + 
phenylalanine).
No significant correlations of mean sleep cycle 
length with any of the plasma amino acid levels or ratios 
were found.
F. THE RELATIONSHIP BETWEEN DIET SUPPLEMENT CONDITION
AND TIME OF GOING TO BED
In a post-hoc treatment of the data, time of going 
to bed was examined in relation to diet supplement condition. 
As the experimental method provided that subjects determined 
their own bedtimes, it was subsequently hypothesized that 
subjects^ would elect to retire earlier following carbo­
hydrate supplement as compared with protein, fat or no- 
supplement.
TABLE 4.5 Weight, height and body mass index (w/h^ x 100) 
for each subject on each experimental occasion
Session 1 Session 2
Subject Height Diet Weight the w/h^ Diet Weight the w/h^
(inches) following following
morning morning
(pounds) (pounds)
1 68" P 128.970 2.789 C 126.545 2.737
N 128.529 2.780 F 126.324 2.732
P 128.529 2.780 C 126.545 2.737
2 68" F 146.387 3.166 N
C 146.607 3.171 P 142.860 3.090
F 145.726 3.152 N 144.182 3.118
3 71" P 168.213 3.337 N 171.079 3.394
C 166.890 3.311 F 170.197 3.376
P 166.449 3.302 N 169.095 3.354
4 69 " F 154.285 3.240 C 152.853 3.211
P 154.899 3.254 N 151.421 3.180
F 153.057 3.215 C 151.216 3.176
5 71" N 137.711 2.732 P 138.939 2.756
C 136.483 2.707 F 137.916 2.736
N 136.279 2.703 P 138.120 2.740
6 68.5" C 139.962 2.983 F 139.348 2.970
P 141.190 3.009 N 138.734 2.957
c 139.553 2.974 F 139.962 2.983
7 66" p 129.935 2.983 N 132.800 3.049
F 129.731 2.978 C 132.800 3.049
P 129.731 2.978 N 131.777 3.025
8 73" N 122.364 2.296 F 124.001 2.327
P 124.411 2.335 C 125.024 2.346
N 123.387 2.315 F 124.001 2.327
9 73" C 149.375 2.803 P 151.011 2.834
F 150.193 2.818 N 150.807 2.830
C 150.807 2.830 P 153.058 2.872
10 70" N 154.081 3.145 P 154.285 3.149
F 153.672 3.136 C 153.467 3.132
N 156.741 3.199 P
11 67" C 144.464 3.218 F 144.464 3.218
N 144.873 3.227 P 146.101 3.255
C 144.668 3.223 F 144.259 3.214
12 67" F 129.526 2.885 C 131.572 2.931
N 129.321 2.881 P 131.572 2.931
F 129.731 2.890 c 133.005 2.963
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The number of minutes was calculated from 2100 hours, 
by which time all supplement drinks were consumed, to the 
start of polygraphic sleep recording - 1lights out1 - for 
each experimental night (Table 4.6). An analysis of 
variance with diet and subject as factors was carried out 
for each of the treatment conditions.
These analyses showed that:
a) the mean time of going to bed relative to 
supplement intake varied significantly from diet to diet 
(p = <0.05):
b) and from subject to subject (p =<0.001);
c) there was no interaction between diet and 
subject.
In a planned comparison of the carbohydrate condition 
against the fat, protein and no-supplement conditions, the
total number of minutes elapsed from intake to bedtime was
/
found to be significantly lower following the carbohydrate 
drink (p =<0.01, 2-tailed).
G. DIET SUPPLEMENT AND SUBJECTIVE SLEEP QUALITY SCORES.
An analysis of variance was carried out, with diet 
and subject as factors, for average subjective sleep 
quality scores based on the first two nights from each 
session (Table 4.7).
These analyses showed that:
a) subjective sleep quality did not vary signific­
antly from diet to diet:
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Table 4.6 Minutes elapsed between drinking diet supple­
ment and electing to go to bed, based on the 
first two nights from each session. The fig­
ures in parentheses are values for the third 
night of each session, used in the estimate 
of variation* in the analysis of variance, 
below.
Diet/
Subject
No supple­
ment
Fat Carbo­
hydrate
Protein
1 165 144 80 (148) 115 (143)
2 204 (156) 170 (175) 170 187
3 97 (166) 136 102 89 (131)
4 164 175 (165) 100 (157) 145
5 152 (154) 206 148 150 (149)
6 137 171 (152) 140 (131) 173
7 148 (164) 153 164 (159) 165
8 315 (307) 265 (270) 278 307
9 137 166 141 (157) 144 (135)
10 160 (174) 178 152 165
11 206 141 (145) 170 (175) 133
12 160 153 (122) 118 (113) 114
Total 2045 2058 1763 1918
Mean 170.4 171.5 146.9 159.8
ANOVA TABLE
Source S.S. D.F. M*S. F Sig.
DIET 4718.2 3 1572.7 3.62 5%
SUBJECT 89 783.7 11 8162.2 18.8 *0.1%
DIET x SUBJ. 15258.8 33 462.39 1.06 N.S.
Total 109760.7
Estimate of 
variation* 9999.5 23 434.76
(23 pairs)
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b) . subjective sleep quality did not vary signifi­
cantly from subject to subject;
c) there was no significant interaction between 
diet and subject.
Subjective sleep quality scores were measured from 
right to left; that is from the extreme right limit of 
the line on the analogue scale (see Figure 3.1) to the 
point which the subject marked with a vertical line.
Thus the higher the subjective sleep quality score, the 
closer to the end of the scale designated 'very good1.
H. SUBJECT'S DIETARY INTAKE
Table 4.8 shows the amount eaten by the subjects in 
grams of carbohydrate, fat and protein and kilocalories, 
based on their self-recorded dietary histories. Calcul­
ations for the 3-day Pre-Study average are shown as well as 
those for the subsequent individual study days. , The type 
of supplement given is indicated by a "plus" sign (+) in 
the appropriate column. This supplementary amount was 
given in addition to the number of grams which appears in 
the column/based on the subject's Pre-Study average for 
that dietary constituent as described previously. Where 
no supplement was given according to the experimental pro­
tocol, no "plus" sign appears in the Table.
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CHAPTER FIVE 
DISCUSSION
132
Addressing the physiological "Regulation of Feeding
and Drinking", Brobeck concludes that "food is ........
without any doubt the oldest and most widely used tran­
quillizer" (Brobeck/ 1960). His summation is consistent 
with biological observations relating hunger with increased 
arousal of various kinds, and satiety with decreased 
arousal. It may be viewed as a logical extension of 
theories about the function of phylogenetically ancient 
reflexes, instincts or drives, and their patterning, as 
in rest/activity cycles. Some of these experimental
theories and observations have been presented in Section
1
A of the Literature Survey (see Chapter 1, pp 2-28)
Brobeck's conclusion may also reflect common wisdom, 
although the sheer variety of rest, activity, hunger and 
feeding in humans may confuse systematic study of the ways 
in which they inter-relate. There are probably myriad 
subtle and complex examples of the tranquillising affect 
of satiation, all with their respective biochemical, 
physiological and behavioural correlates. I believe a 
powerful psychological dimension of rest, hunger and 
activity also operates to augment the variety of expression 
these fundamental drives assume. This may be inferred 
from the Bryan and Carlson (1962) and Christie and 
McBrearty (1979) studies discussed earlier (pp 6-10) 
in which both progressive and acute starvation were met 
with qualitatively differing individual arousal responses.
It may also be inferred from work in psychiatry with 
eating disorders (eg. Crisp, 1967) where weight, hunger 
and activity levels may be seen to have psychodynamic 
meaning quite apart from and at variance with the physiology
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of energy balance. The prevalence of disturbed appetite 
and sleep within psychiatric illness in general, reported 
to vary as a function of mood (Crisp and Stonehill, 1973), 
further implies the significance of ways in which the mind 
may express its own hunger, arousal and need to rest or 
withdraw. One model of the correlation between eating 
and both neurophysiology and behaviour is suggested in the 
work in cats on "post-reinforcement synchronization" 
(Marczynski et al, 1968: Roth et al, 1967: Sterman and
Wyrwicka, 1967), in which a "functional overlap" was 
observed between the condition of being rewarded (psycho­
logical satiation?) and cortical synchrony (pp 21-23)
A brief review of work relating psychological symptoms to 
disorders of eating and arousal appears in Chapter 1, 2,b 
(pp 13 - 16).
Within the wide range of human expression of rest,
hunger and activity, the relationship between sleep - as
perhaps the most extreme form of the drive to rest - and
dietary intake provides rich and accessible experimental
material for the significance of metabolism for relative
arousal. The diminished awareness of the sleeper means
that this phase of his rest/activity cycling is less
subject to alteration by immediate environmental responses,
allowing for increased control of an experimental variable.
I would like here to acknowledge the thinking of Professor
A.H. Crisp, who more than a decade ago postulated the
significance of these concepts from clinical observations
of the syndrome anorexia nervosa (Crisp, 1967), and who
has subsequently worked to validate them experimentally
%
in the field of nutrition and sleep.
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Many dietary variables both long-term and short-term 
have been reported to affect sleep, including habitual 
eating pattern, digestibility, food temperature and 
desirability, as well as the specific constituents, fat, 
carbohydrate and protein (Chapter 1; A, 4, pp 24-28)
Where it exists, discussion of the physiology underlying 
such effects has been largely speculative as so little 
has been known, until recently, about the physiology of 
sleep itself.
In one notable exception, Adam and Oswald (1977) 
have presented the case for a correlation between activity/ 
inactivity rhythms at the cellular level and catabolic/ 
anabolic balance, as indexed by the energy charge. The 
excitement of this work lies for me in the author's 
argument that cellular energy charge - with its implica­
tions for processes such as adenine nucleotide activity 
and protein synthesis - is significant for the global 
states of sleep and wakefulness. In their view, "(it) 
seems that, through evolution, rhythms of mitosis have 
become entrained to the variations of energy state 
associated with the rest/activity cycle." Perhaps, 
in another sense, cyclical fluctuations in the energy 
charge can be said in themselves to constitute, at the 
biochemical level, what we experience as rest/activity; 
one dimension of which is the sleep/wakefulness cycle.
And perhaps it is the oscillations of the energy charge 
which may be entrained, for reasons of species and 
individual advantage to, say, the solar light/dark cycle.
How might such entrainment occur? One known 
mechanism is feeding pattern; a mother gradually entrains
her infant to a diurnal rhythm by increasingly imposing 
scheduled feeds in place of feeding on demand. In their 
elegant series of experiments in rats (see pp 12, 16, 23) 
Danguir and Nicolaidis documented the "Dependence of 
Sleep on Nutrients* Availability" (Danguir and Nicolaidis, 
1979). Their work demonstrates "highly significant 
correlations between meal size and the duration of sleep 
within the inter-meal interval following that meal"
(Danguir and Nicolaidis, 1977). It further suggests that, 
in the rat, fluctuations of sleep and feeding are dependent 
on both the nature and the degree of utilization of meta­
bolizable substances at the cellular level (Danguir and 
Nicolaidis, 1980a). These observations were strikingly 
confirmed in a study designed to challenge the normal 
circadian distribution of rat sleep and feeding patterns, 
by manipulating the light-dependent lipogenetic vs 
lipolytic rate; ie, the "sequestration vs release of 
circulating metabolites". Under control conditions 
infusion of insulin (lipogenetic hormone) during the 
normally light period alternating with epinephrine 
(lipolytic hormone) during the normally dark period, 
resulted in a "complete inversion" of the usual rat 
circadian sleep/eating patterns, and of the correlations 
between them (Danguir and Nicolaidis, 1980b). In terms 
of the Adam and Oswald work, Danguir and Nicolaidis may 
have been reversing the normally light/dark entrained 
cycles of cellular energy charge in their rats, resulting 
in a shift in (1) rates of synthesis and degradation, and 
(2) the intervals at which nutrients were required as 
substrates.
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There are probably many biological cues which signal 
to an organism its need for the increased synthetic activity 
associated with rest and sleep, and the availability of 
metabolizable substances appropriate to such processes.
These two physiological conditions, and the way in which 
they are interpreted by the organism, may underly behavioural 
patterns of food intake, rest and activity. The work of 
Fara et al (1969) and Rubenstein and Sonnenshein (1971) 
exploring an hypothesized central sedating effect of gut 
hormones cholecystokinin - pancreozymin, suggests one 
mechanism by which an organism may be cued to the presence 
of fat (pp 19-21). I think another such mechanism may 
be brain tryptophan level, signalling the availability to 
the organism of carbohydrate.
Data has been presented in animals and humans to 
suggest that tryptophan and its metabolites 5-HTP and 5-HT 
may be positively correlated with various measures of 
decreased arousal, or hypnotic effect. Evidence has also 
been cited, in animals, that it is brain levels of trypto­
phan which are significant for such effects; and that 
metabolism of carbohydrate may be associated with a quanti­
tative advantage for tryptophan in competition for neutral 
amino acid blood/brain transfer. Finally, positive corre­
lations between ingestion of carbohydrate and decreased 
arousal, including sleep variables, have been reported in 
animals and humans (Chapter 1; B , pp 28-46) .
These findings suggest the following model :
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fcHO — Plasma tryptophan ___ A brain
tyr; phe; leu; tryptophan
isol; val
 ►  f HTP ----► \ 5-HT ■— »■ ■■ ► | hypnotic effect,
which the present study set out to test in man.
The results of the study appear to endorse, in a 
population of human subjects, the carbohydrate-associated 
increase in plasma tryptophan levels, compared with other 
neutral amino acids, previously reported in animal studies. 
The hypothesized correlation of this biochemical finding 
with sleep neurophysiology and self-reports has not been 
demonstrated, however. The significance of these data 
for the proposed model of diet, tryptophan metabolism and 
sleep can be speculative only. Viewing the diet and amino 
acid data alone, however, the correlations obtained may 
support a role for carbohydrate metabolism in the pathway 
to brain serotonin synthesis.
Compared with average values in the no supplement 
condition (Table 4^1, page 74), the average levels of all 
three amino acids fell in association with high carbohydrate, 
consistent with a shift from plasma to muscle in the presence 
of insulin. However, plasma tyrosine and phenylalanine 
levels fell to a relatively greater extent, reaching their 
lowest levels in the high carbohydrate condition, as com­
pared with the high fat, high protein and no supplement 
condition. Whereas average tryptophan levels were lowest 
in the high fat condition. Tyrosine and phenylalanine 
also fell in association with the high fat diet, but 
relative concentrations of the three did not differ markedly 
from the no supplement condition as indicated by the corres­
ponding ratios.
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These findings are in agreement with the Lipsett 
et al (1972) report of a drop in total tryptophan following 
glucose infusion in human subjects, and are consistent with 
their finding that the above decrease was confined to the 
free fraction. This is supported by the relatively 
greater decrease in total tryptophan associated with the 
high fat condition, in accordance with the work of Fernstrom 
and Wurtman (1971a; b) and Madras et al (1973) in rats, 
suggesting that high levels of free fatty acids may have 
saturated enough extra albumin to limit or suppress trypto­
phan binding. In the high carbohydrate condition, bound 
tryptophan may have functioned - under the influence of 
insulin to free albumin from existing free fatty acid bonds - 
to keep total tryptophan in rough equilibrium, as against 
marked reductions in the levels of the other neutral amino 
acids.
Given the above conditions, the hypothesis would 
predict increases in brain tryptophan, 5-HTP and 5-HT 
in these subjects, associated with the high-carbohydrate 
supplement as compared with the high fat, high-protein 
and no-supplement conditions. Previous work suggests 
increases in one or more of the above compounds to be 
correlated with increased hypnotic effect as measured 
polygraphically and subjectively. As these correlations 
have not been replicated in the present study, one or more 
of the following implications may apply:
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It may be that the tryptophan/tyrosine ratio did 
not reflect the plasma ratio of tryptophan to the rest 
of its large neutral competitors. It has been reported 
(Fernstrom et al, 1973) that brain tryptophan levels 
in rats correlate as closely with its ratio in plasma 
to isoleucine, leucine, tyrosine, or valine, as with 
its ratio to the sum of the competitors. Phenylalanine 
was found to compete least effectively, within a normal 
physiological range, for transport carrier sites.
Plasma tyrosine concentrations were therefore used in 
this study as an index of competitor inhibition of 
brain tryptophan uptake. Plasma phenylalanine concen­
trations were used to provide further data about its 
relative effectiveness in such competition. In view of 
the results, however, an extension of the work to include 
analysis of other amino acids may be worth undertaking.
Average tryptophan/tyrosine was found to be 
significantly (p =<0.01) increased in the eight hours 
following carbohydrate supplement in these subjects.
This result suggests ingestion of large amounts of carbo­
hydrate relative to protein and fat may be associated with 
an advantage for tryptophan blood/brain transfer as 
hypothesized. In the absence of any correlation with 
sleep variables, however, one possible interpretation 
must be that plasma tryptophan/tyro sine was not a true 
index of the competition for carrier sites. The ratios
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obtained when the phenylalanine results are included 
may support the above interpretation, as tryptophan 
levels appear in this analysis to be increased to a 
relatively greater extent in association with the 
protein supplement. It should be noted, however, that 
for reasons of palatability, the preparation used to 
provide the protein supplement contained essential 
amino acids only (see TABLE. 3.2, page 59), not includ­
ing tyrosine.
Tyrosine is synthesized from phenylalanine in 
the liver. The average plasma tyrosine value associated 
with the protein supplement in these subjects, 70.48 
nmol/ml, was virtually the same as that for the no­
supplement condition, 69.03 nmol/ml; suggesting that 
the large increase in phenylalanine levels associated 
with the protein supplement - 107.80 nmol/ml, compared 
with 79.29 nmol/ml in the no-supplement condition - 
did not result in an increase in its conversion to 
tyrosine. This may be consistent with the Daniel et al 
(1976) finding that L-phenylalanine was the most 
effective of the aromatic amino acids in inhibiting 
transport to the brain, in contradiction to the 
Fernstrom et al (1973) work.
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Little is known of the individual 24-hour patterns 
of circulating amino acid levels in man, and the influences 
which determine them. Chen et al (1974) noted a possible 
diurnal variation in free plasma tryptophan levels, with 
high readings in the first half of the night, and in inverse 
relationship with bound tryptophan. Total plasma tryptophan 
levels showed little change in range of fluctuations through­
out the night. A two-fold diurnal variation in plasma 
tyrosine concentrations has been reported in six human males 
(Wurtman et al 1967), which were found to be lowest between 
01.30 and 02.30 hours, rising to a peak by 10.30 hours, with 
a sharp fall at 21.30 hours. This rhythm was found to 
persist during two weeks' protein deprivation and may 
reflect an endogenous cycle consistent with increased trypt­
ophan blood/brain transfer associated with the sleep phase 
of the diurnal rhythm. Feigin et al (1967) have reported 
a similar diurnal variation in total serum amino acid 
concentrations. To what extent this variation in the total 
may be a function of the activity of one or more key compounds 
is unknown; nor is the capacity of various inputs, such as 
food intake or physical exercise, to influence diurnal 
variation understood.
No conclusions can be drawn from the present results 
as to the relative effectiveness of tyrosine and phenylalanine 
in competition with tryptophan for access to brain.
It may be, in contrast to the views of Wurtman (1975) 
that the ratio of total plasma tryptophan to total levels of
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the remaining neutral amino acids does not accurately 
account for the activity of its free and bound forms. The 
complexity of the binding properties of serum albumin is 
increasingly recognised (e.g. Rosenoer et al 1970; Bowmer 
and Lindup, 1978; Schneider, 1977; Bruderlein and Bernstein, 
1979). Coibion and Laszlo (1979) have recently reported 
the isolation of both low-affinity and high-affinity 
tryptophan binding sites on the human serum albumin molecule. 
The physiological significance of strong versus weak 
tryptophan-albumin bonds for total tryptophan and its 
'effective* concentration during blood/brain transfer is 
not clear.
\
The selective availability of tryptophan to its other 
metabolic pathways in these subjects cannot be determined.
In addition to its role in the formation of body protein 
and serotonin, tryptophan is substrate in the pathways to 
tryptamine and nicotinamide. Kynurenine, the first major 
metabolite of tryptophan on the pathway initiated by the 
liver enzyme tryptophan pyrrolase, has recently been reported 
to bind to albumin and to be present in brain (Joseph and 
Kadam, 1979). Peripheral administration of kynurenine 
has also been reported to reduce rat brain 5-HT levels, 
perhaps via inhibition of tryptophan uptake (Green and 
Curzon, 1970).
It may be that brain serotonin synthesis was increased 
in these subjects in association with the high carbohydrate 
load, but resulted in a greater rate of 5-HT turnover in the
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raphe nucleii, rather than change in the amount of neuro­
transmitter released, or in a greater rate of conversion 
elsewhere in the brain. For instance, an inverse 
periodicity obtains between serotonin and its metabolite 
melatonin formed in the pineal (e.g. Vaughan et al 1976), 
such that a high night time pineal melatonin content is 
180 degrees out of phase with pineal serotonin content. 
According to Curzon and Marsden (1975), the existence of 
two (or more) storage pools of 5-HT in the brain raises 
the possibility that total brain 5-HT and functional brain 
5-HT are not related. Moreover, as Costa and Meek (1974) 
suggested "confirmation of Fernstrom and Wurtman1s hypothesis 
requires a demonstration that dietary-induced modifications 
of brain serotonin concentration do have functional conseq­
uences for behaviour since it is possible that alterations 
in 5-HT synthesis may have little influence on amount of 
5-HT at receptor sites".
Earlier, Grahame-Smith (1973) postulated that normally 
5-HT may be synthesized in excess of normal requirements 
and stored and metabolised intraneuronally without ever 
becoming functionally active. He commented: "I find it 
very difficult to conceive that the regulation of a crucial 
functional pool of neuronal 5-HT can depend upon the fine 
regulation of tryptophan hydroxylation when this enzymatic 
activity is so dependent upon the brain tryptophan concen­
tration which is obviously not finely controlled".
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Nevertheless, both behavioural and neurophysiological 
changes have been correlated with the indoleamine precursors 
t r y p t o p h a n -and 5-HTP. Given the lack of correlation with 
sleep variables in the present work, however, it would be 
useful in interpreting the significance of the amino acid 
ratios obtained to have measurements of 5-HIAA and melatonin 
levels in these subjects.
Assuming the amino acid ratios in these subjects were 
significant for the pathway to brain serotonin as suggested 
in the model, how can the lack of correlation with EEG 
and subjective sleep variables be interpreted?
The polygraphic sleep recording in these subjects 
presentsseveral problems of method. The extent to which 
experimental technique alters the nature of the phenomenon 
observed is a dilemma inherent to research. It is perhaps 
particularly difficult to control in sleep investigations 
as little is known about the relative determinants of the 
sleep/wake cycle in a given individual in a given 24-hour 
period.
The question of whether or not to impose a laboratory 
schedule for time spent in bed is, I think, a difficult 
issue for sleep research. Uniformly beginning polygraphic 
recordings at 23.00 hours, for example, may result in an 
artificial sleep latency the significance of which is open 
to question. Waking subjects at a set time may also 
distort sleep data for the night in question and, perhaps, 
the subsequent night or nights as well.
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With the objective to test for the effect of a 
dietary variable on sleep architecture, I specifically 
elected not to impose a fixed * lights off/lights on1 
laboratory schedule. Subjects were prepared for bed as 
soon as they indicated they were ready to retire and there­
after recorded until they spontaneously awoke for the day.
It could be argued, however, that a defined sleep recording 
time would have been an appropriate control, particularly 
as these subjects were carrying out their usual activities 
in the daytime. Although efforts were made, even apparent 
external cues - such as morning commitments which required 
waking at a certain time, or.the experience of an unexpect­
edly stressful day - could not consistently be controlled 
for. It is possible that an older population with more 
established, regular lifestyles would have been more 
appropriate subjects for this experiment.
Simultaneous blood sampling and the presence of an 
indwelling cannula during the night may also have contamin­
ated the sleep data for these subjects. This is an 
established procedure in sleep laboratories, based on a 
technique originally developed by Vankirk and Sassin (1969), 
and much of what is published about the biochemistry of 
sleep and its correlation with neuroelectrical activity is 
owed to it. The experimenter is experienced in the 
technique. Its inclusion in the present study was necessary 
to the hypothesis that diet influences sleep through its 
effects on amino acid metabolism. However, the intrusive
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nature of all-night blood sampling in this population 
cannot be evaluated. Sampling occurred on all diet/nights 
and in this sense represented a controlled condition, however 
a potential sleep disturbing effect large enough to distort 
the results of the study cannot be discounted. I note 
that Lacey et al. (1978) reported associations between 
glucose and amino acid parenteral infusion and sleep 
variables. While the techniques obviously differ, both 
involve an indwelling cannula and immobilisation to some 
extent.
It is clear from Table 4.8 (Subject's Dietary Intake) 
that on some study days the subjects ate very different 
quantities of food than was suggested by their 3-day pre­
study averages. Only Subject 2's dietary intake was 
qualitatively and quantitatively consistent over the period 
of study. Apart from Subjects 5 and 9, who ate an average 
of 400 Kcal more on study days, the other nine subjects 
reduced their food intake, on average, by about 560’Kcal 
on study days; one subject, number 11, consistently ate 
an average of 1166 fewer Kcal during the study than he had
during the assessment days. In five of the subjects, i.e. 1,
4, 6, 7 and 10, the reduced food intake occurred most markedly 
in the second experimental session. Six subjects, i.e. 1, 3, 
4, 6, 7 and 8, had their lowest intake on the last day of
the study (Session 2, Day 3). These observations are based •
on calculations of the subject's self-reported freely-chosen 
daily diets, not including the experimental supplements.
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The subject's diet was monitored during the study to 
provide background information about the way they were 
eating. Daily variations in dietary intake did not influence 
the amounts of experimental supplement, which were based on 
Pre-Study food intake, and administered over and above what­
ever the subjects chose to eat on study days.
The amount of individual variation in the day-to-day 
eating of these subjects was considerable, however, and 
may in itself have influenced the findings. All subjects 
ate an evening meal in the laboratory, however, in addition 
to which they drank their supplements of fat, carbohydrate 
or protein. If, as is particularly suggested in the last 
day with Subjects 1 and 4, the bulk of their food intake 
for those days was taken at this time, they were in any 
case in an acute state of carbohydrate, fat or protein 
supplement.
It may be, however, that the variations in the whole 
day's diet experienced by these subjects was an influential 
factor in the short-term effects of the experimental supple­
ments taken with the evening meal. The finding by Danguir 
and Nicolaidis (1979) in rats of positive correlations 
between meal size and the amount of SWS and PS in the two 
subsequent inter-meal intervals may be important here.
Their work suggests that fluctuations in sleep and feeding 
are dependent on both the nature and degree of utilization 
of metabolizable substances at the cellular level (Danguir 
and Nicolaidis, 1980). It is this cellular degree of
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utilization that cannot be estimated in these subjects.
What is known is that humans do not necessarily achieve 
energy balance consistent with stable weight over a period 
of 24 hours, but within several days or a week. This has 
been demonstrated in a population of schoolgirls (Lacey 
et al. 1979) and may well apply in other populations, perhaps 
especially in young adults such as the subjects in this study.
What caused these subjects to vary their energy intake 
so markedly within the few days and months of the experiment 
is not clear. It may be that in some cases they were 
adjusting their eating patterns in response to a supplement 
ingested the night or nights before, or in anticipation 
of an evening supplement. The subjects were not informed 
in advance of their individual supplement/no-supplement 
pattern in the design of the study. Nonetheless they 
were not blind to the nature of the variable and - by the 
end of the Second Session - may have been adjusting their 
diets accordingly. However such a speculation is not 
consistently suggested by the Table 4.8 data.
It may also be that the general reduction in food 
intake in these subjects over the course of the experiment 
corresponds to an annual variation in energy intake. The 
experiment was conducted in the months September to March.
This means that the subjects were recruited, and their 
Pre-Study dietary histories taken, in the autumn, while 
the second experimental sessions for Subjects 9 - 1 2  took
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place in March. While the data (Table 4.8) do not suggest 
this to be a consistent trend, it may be that some seasonal 
adjustment in energy requirements is reflected in the 
way in which the subjects ate during this time.
It may be appropriate to consider the reliability 
of accepted ways of scoring sleep polygraphs. An average 
sleep record includes about 1500 20-second scoring epochs, 
or intervals. This translates into an equal number of 
decisions, based sometimes on ambiguous information, which 
must nonetheless be categorical. No matter how rigidly 
one adheres to the criteria set down in the Rechtschaffen 
and Kales manual, there is likely to be an element of 
reader judgement, even where records are technically of 
good quality. The scoring of trends as opposed to each 
20-second epoch, or sometimes scoring trends (e.g. SWS 
onset) and sometimes scoring epochs (e.g. REM onset) 
within a single record according to a reader's personally 
evolved interpretation of the manual, may result in 
significant differences between two experienced readers' 
scores of the same record. A consistent interpretation 
may be reached by one person reading all records in a
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particular study. Where work from different groups is 
compared, however, or relatively low levels of significance 
are quoted between experimental variables and sleep stage 
data, I wonder whether the sensitivity of our measure and 
our ability to interpret it reliably, allow such correlations 
to be meaningful. Certain sleep variables may be more 
likely to reflect different judgemental styles than others. 
Total Sleep Time may be more consistent between scorers 
than transition Stages 1 and 3, for example.
In an effort to examine the validity of the sleep 
data scored by the experimenter in this study, a random 
sample of 12 records was re-read by another reader, also 
esqperienced in scoring by the accepted international 
criteria. The scores for the different sleep variables 
were compared to arrive at correlation co-efficients as 
a measure of inter-reader reliability. (Table 5.1) v
The correlations suggest the two readers were scoring 
highly consistently (r =>.92) on variables TST, sleep 
latency, Stage 4, NREM sleep taken as a whole, Stage REM 
and REM latency.
The sleep variables which showed weaker correlations 
between the two interpretations (r =<.9) are stages which 
share defining characteristics, according to the Rechtschaffen 
and Kales manual. For example, the high correlations for 
Stage 4, but the low values for Stages 2 and 3, may indicate
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Table 5.1
INTER READER-RELIABILITY
Variable r
TST .9960
Sleep Latency .9921
Stage 0 .8432
Stage 1 .6644
Stage 2 .8628
Stage 3 .3487
Stage 4 .9538
NREM .9609
Stage REM .9287
Movement Time .7331
REM Latency .9746
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that the two readers score the 2/3 transition, with 
increasing delta activity, differently. Similarly, the 
low correlations for MT and Stage 0 may suggest the 
readers score these two variables interchangeably, but 
according to different criteria in each case. Particularly 
in scoring transitions from Stage MT to 2, say, or 2 to 3, 
the effect of an individual reading style, built up on 
experience, may result in technically valid - i.e. following 
the manual - but relatively unreliable - in the sense of 
repeatable - total scores for all sleep stages. I would 
like to see more reader reliability studies in published 
sleep literature, and statements about any specific scoring 
bias adopted by a laboratory or an individual, within 
the internationally agreed criteria. The sleep data for 
the present study were scored epoch-by-epoch (20-seconds), 
for as sensitive a profile as possible, as opposed to 
scoring overall trends.
Subjective sleep quality scores ranged widely in 
these subjects, from a low of 2.1 to a high of 10.0, based 
on a 10cm analogue scale where 0 = 'extremely bad' and 
10 = 'very good'. Subjective experience of sleep was not 
found to be related to diet, which may be consistent with 
a random, non-specific stress effect of blood sampling as 
discussed earlier. A mean sleep quality of 6.2 (based on 
12 subjects, 71 sleep nights) was reported by the subjects 
under these laboratory conditions. While this figure 
could be expressed as 'slightly better than average sleep',
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it probably represents relatively poorer reported sleep 
than would’ be expected in a population of this age.
In retrospect, it would have been valuable to include, 
in addition to the morning subjective sleep quality assess­
ments, a measure of subjective alertness administered 
regularly in the interval after dinner+supplement up to 
the start of sleep recording. Oswald et al (1966),
Griffiths et al (1972), Greenwood et al (1974) and Hartmann 
et al (1977) have reported increases in subjective drowsiness 
associated with tryptophan ingestion both anecdotally, and 
using such measures as the Stanford Sleepiness Scale. In 
the light of the present hypothesis, a similar increase 
would be predicted following a glucose load of the type 
administered in this study.
The time elapsed from the time the subjects drank the 
supplements to the time they decided to go to sleep (Table 
4.6, page 128) may be relevant here however. Statistical 
analysis of the data suggests that the carbohydrate supple­
ment was associated with a tendency to go to bed earlier 
than were the other supplements. On first view, this 
appears to be due largely to Subject 1. Closer analysis 
reveals that 5 of the; subjects (i.e. 1, 4, 5, 8 and 10) 
elected to go to bed earliest in the carbohydrate 
condition. Seven subjects (i.e. 1, 2, 4, 5, 8, 11 and 12)
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retired earlier after carbohydrate supplement than in 
the baseline no-supplement treatment: five of these also 
retired earlier after the fat and protein drinks, and 
three after the protein drink alone, however these bed­
times were still later compared with the no-supplement 
nights than were the bedtimes on carbohydrate supplement 
nights.
Because in the study design not every subject 
experienced each supplement condition the same number of 
times (see page 57), the statistical analysis for this 
variable, as for all the other variables tested in the 
study, was based on the first two nights from each session. 
As no carry-over effect was revealed, however, the data 
for the third night of each session was incorporated as 
an estimate of individual variation in all the analyses of 
variance. These analyses revealed that the bedtimes in 
the different diet conditions varied significantly at the, 
.05 level: and the planned comparison of the carbohydrate 
condition with the other three conditions revealed a 
difference significant at the .01 level (2-tailed).
The conclusions to be drawn from these data seem 
to me to be the following: (1) that in some subjects a 
carbohydrate supplement is associated with a tendency to
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retire to bed earlier than with either fat or protein 
supplements, or no supplement at all; (2) that in some 
subjects any supplement is associated with a tendency to 
retire to bed earlier as compared with no supplement.
The latter conclusion is consistent with reports 
in the literature (see page 27; 2.e.) of lowered 
arousal following ingestion of both protein and fat. 
Perhaps an indirect measure of increased drowsiness 
following ingestion of carbohydrate may also be 
inferred from the finding that overall my subjects 
spontaneously went to bed earlier in the glucose 
supplement condition, compared with either protein, 
fat or no-supplement. Such a conclusion would be 
consistent with the reduced sleep latency which has 
been reported with tryptophan loading (Williams et al, 
1969; Hartmann, 1970; Hartmann et al, 1971; Hartmann 
and Elion, 1977; Griffiths et al, 1972). It may be, 
for normal subjects, that variations in sleep latencies 
recorded in the laboratory would be reflected in 
variations in the time of going to bed outside the 
laboratory; i.e., where the subject was free to 
determine for himself when to retire based on a variety 
of cues including, perhaps, brain tryptophan level.
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It may be that drinking the supplements represented 
an abnormal stress sufficient to compromise the experiment, 
however, subjects1 spontaneous comments did not suggest 
this to be the case. The dietary variable in the experiment 
was exhibited in the form of supplement drinks to allow 
simple preparation of a constituent load designed to provide 
a comparable metabolic stimulus for each individual subject.
The amount of extra fat, carbohydrate or protein given to 
each was calculated to be a percentage of his usual daily 
intake. In consultation with dietitions, it was considered 
unlikely that normal foodstuffs could be prepared or eaten 
in the quantities required to constitute the experimental 
loads. Comments ranged from mild approval to mild disapproval, 
directly randomly at all of the drinks. There was a 
suggestion in two subjects, on one occasion each, that the 
fat supplement was difficult to tolerate. On no occasion 
was a supplement drink refused, however. An indication 
of the significance of the different drink conditions for 
the subjects1 subsequent experience may be inferred from 
their sleep quality reports which did not differ signific­
antly following nights in which no supplement was taken.
In contrast to previous studies in which diet has 
been reported to affect sleep, the present study looked 
at the short-term impact of a dietary variable on a single 
night*s sleep. Earlier work has altered food intake 
throughout the day for one or more days (Phillips et al,
1975; Al-Marashi and Freemon, 1977; Hartmann et al, 1977);
152
or, repeated the same experimental snack condition over 
several consecutive nights (Stanley and Teschler, 1932; 
Giddings, 1934; Laird and Drexel, 1934; Brezinova and 
Oswald, 1972). With particular relevance to the present 
work, Porter and Horne (1981) recently reported that the 
progressive increase in CHO food supplements, taken as a 
late evening supper, was associated with a progressive 
increase in REM sleep during the first half of the night; 
and a decrease in wakefulness and light sleep throughout the 
night. The three supplements were given as normal food­
stuffs, on three consecutive nights each.
In the light of these and previous reported findings, 
it may be that in Man there is a threshold interval beyond 
which a 'dietary variable must extend before correlations 
may be seen in polygraphic sleep. This may imply that 
diet affects sleep variables most significantly via 
intermediary changes in, for example, metabolic rate, 
energy stores, or body weight. Support for such a view 
may be taken from the work of Crisp et al (1971) and Lacey 
et al (1975), who found sleep variables to be significantly 
correlated with progressively increasing weight in anorectics 
maintained on a constant diet; from the Danguir and Nicol­
aidis (1979) findings that relationships between sleeping 
and eating in the rat obtained in the lean but not in the 
obese groups; and from reported correlations by Adam (1977a,b) 
between body weight and REM variables, including sleep cycle 
length.
ADDENDA
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Addendum I Normal Sleep
It is currently accepted that there are two qualitat­
ively distinct kinds of sleep, which cycle throughout the 
sleep period of normal individuals: non-rapid-eye-movement,
or NREM sleep: and rapid-eye-movement, or REM sleep. Sleep 
stages have been defined according to characteristic electro- 
encephalographic, electro-oculographic and electro-myographic 
patterns, by which NREM sleep is further divided into Stages 
1, 2, 3, and 4.
MATERIAL REDACTED AT REQUEST OF UNIVERSITY
Physiologically, the NREM stages correspond with decreas­
ing autonomic activity, while REM sleep is a time of heightened 
but variable autonomic activity. Stages 3 and 4, which predom­
inate in the early hours of sleep, are known collectively as 
slow-wave sleep (SWS) and are normally accompanied by a sharp 
rise in plasma growth hormone. REM sleep always follows a 
period of NREM sleep in normal individuals, and appears about 
once every 90 - 100 minutes, increasing in length as sleep 
progresses. REM periods are characterized by abolition of 
skeletal muscle tone, rapid eye movements (REMs) and relatively 
fast EEG activity similar to relaxed wakefulness or Stage 1.
REM sleep is thus also known as paradoxical sleep (PS).
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Subjects awoken during REM periods often report dreams 
laden with fantasy and emotion/ whereas reports from NREM 
sleep are usually more thought-like.
There is a wide range of normal variation in the amount 
of sleep needed by different individuals. Within a single 
individual, time spent asleep is not only age-related but 
probably varies around a personal norm. While habitual 
*long sleepers* (more than nine hours) and * short sleepers* 
(less than six hours) are recognized, most adults sleep about 
7% hours, or 450 minutes, in an average night. Proportionally, 
normal sleep consists of approximately 1 - 2 %  Wakefulness, 
5 - 6 %  Stage 1, 50% Stage 2, 6 - 7 %  Stage 3, 13 - 15% Stage 4, 
and 20 - 25% Stage REM. For a more detailed discussion of 
polygraphic definition of sleep stages, see Chapter 3 pp 63 - 
65, and Chapter 5 pp 146 - 149.
MATERIAL REDACTED AT REQUEST OF UNIVERSITY
Figures based on data from the Sleep-Wake Disorders Center, 
Montefiore Hospital, New York are reprinted with permission 
from Newsweek/July 13, 1981, p 50.
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Addendum II Sleep characteristics - mean values for
the group, based on 70 occasions.
Sleep Stacre Minutes Minimum Maximum S. D. %TS'
Total Sleep Time 
(TST) 454.4 319.7 555.0 53.5
Sleep latency 15.8 2.3 68.3 14.5
Stage 0 11.3 0.0 49.0 9.7 2
Stage 1 21.5 2.3 74.0 12.1 5
Stage 2 233.0 117.0 299.7 37.5 51
Stage 3 22.5 5.0 59.0 10.8 5
Stage 4 51.6 0.0 100.7 24.7 11
REM 120.7 69.7 179.3 23.3 27
Movement Time 5.5 0.0 16.7 3.4 1
REM latency 70.0 33.3 169.0 22.9
Total Recorded Time 
i.e. Time in Bed 
(TRT)
481.5 343.0 580.7 56.2
Sleep Efficiency 
TST/TRT .96 .84 1.00 .04
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Addendum III Sleep histograms and amino acid values.
Subject
1
2
3
4
5
6
7
8 
9
10
11
12
Treatment Series
PNP
FCF
PCP
FPF
NCN
CPC
PFP
NPN
CFC
NFN
CNC
FNF
CFC
NPN
NFN
CNC
PFP
FNF
NCN
FCF
PNP
PCP
FPF
CPC
Page
158
164
170
176
182
188
194
200
206
212
218
224
N = No supplement 
F = Fat supplement 
C = Carbohydrate supplement 
P = Protein supplement
KEY to graphs:
'lights out' 
tryptophan 
tyrosine 
phenylalanine
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